Form990
Click to see attachment
Department of the Treasury
Internal Revenue Service
Return of Organization Exempt From Income Tax
Under section 501(c), 527, or 4947(a)(1) of the Internal Revenue Code (except black lung benefit trust or private foundation)

MediumBullet The organization may have to use a copy of this return to satisfy state reporting requirements.
OMB No. 1545-0047
2010
Open to Public Inspection
A For the calendar year, or tax year beginning 01-01-2010 and ending 12-31-2010
BCheck if applicable:
CName of organization
The Michael J Fox Foundation
FOR PARKINSON'S RESEARCH
Doing Business As
 
 
Number and street (or P.O. box if mail is not delivered to street address)
CHURCH STREET STATION PO BOX 780
 
Room/suite
City or town, state or country, and ZIP + 4
NEW YORK, NY100080780
D Employer identification number

13-4141945
E Telephone number

G Gross receipts $ 106,255,595
F Name and address of principal officer:
Todd Sherer
Church Street Station PO 780
New York,NY10008
I
Tax-exempt status: (   ) LeftBullet (insert no.) or
J
Website:MediumBullet
www.michaeljfox.org
H(a)
Is this a group return for
affiliates?
H(b)
Are all affiliates included?
If "No," attach a list. (see instructions)
H(c)
Group exemption number MediumBullet  
K Form of organization:
 
L Year of formation: 2000
M State of legal domicile: DE
Part I
Summary
Activities & Governance 1 Briefly describe the organization’s mission or most significant activities: THE MICHAEL J. FOX FOUNDATION FOR PARKINSON'S RESEARCH IS DEDICATED TO ENSURING THE DEVELOPMENT OF BETTER TREATMENTS, AND ULTIMATELY A CURE, FOR PARKINSON'S DISEASE THROUGH AN AGRESSIVELY FUNDED RESEARCH AGENDA.
2 Check this box MediumBullet
3 Number of voting members of the governing body (Part VI, line 1a) .... 3 26
4 Number of independent voting members of the governing body (Part VI, line 1b) .... 4 24
5 Total number of individuals employed in calendar year 2010 (Part V, line 2a) ... 5 68
6 Total number of volunteers (estimate if necessary) .... 6 7
7a Total unrelated business revenue from Part VIII, column (C), line 12 .. 7a 28,493
b Net unrelated business taxable income from Form 990-T, line 34 .. 7b 10,807
Revenues; Prior Year Current Year
8 Contributions and grants (Part VIII, line 1h) ......... 51,252,077 57,111,106
9 Program service revenue (Part VIII, line 2g) ......... 0 0
10 Investment income (Part VIII, column (A), lines 3, 4, and 7d ) .... 99,438 476,177
11 Other revenue (Part VIII, column (A), lines 5, 6d, 8c, 9c, 10c, and 11e) 37,425 34,177
12 Total revenue—add lines 8 through 11 (must equal Part VIII, column (A), line 12)................... 51,388,940 57,621,460
Expenses; 13 Grants and similar amounts paid (Part IX, column (A), lines 1–3 )... 34,683,415 49,441,851
14 Benefits paid to or for members (Part IX, column (A), line 4) .... 0 0
15 Salaries, other compensation, employee benefits (Part IX, column (A), lines 5–10) 5,431,685 6,107,055
16a Professional fundraising fees (Part IX, column (A), line 11e).... 57,500 49,600
b Total fundraising expenses (Part IX, column (D), line 25) MediumBullet4,137,564    
17 Other expenses (Part IX, column (A), lines 11a–11d, 11f–24f).... 4,179,531 4,458,038
18 Total expenses. Add lines 13–17 (must equal Part IX, column (A), line 25) 44,352,131 60,056,544
19 Revenue less expenses. Subtract line 18 from line 12...... 7,036,809 -2,435,084
Net Assets or Fund Balances; Beginning of Current Year End of Year
20 Total assets (Part X, line 16)............ 69,013,965 78,224,899
21 Total liabilities (Part X, line 26)............ 44,985,964 56,622,447
22 Net assets or fund balances. Subtract line 21 from line 20 ..... 24,028,001 21,602,452
Part II
Signature Block
Under penalties of perjury, I declare that I have examined this return, including accompanying schedules and statements, and to the best of my knowledge and belief, it is true, correct, and complete. Declaration of preparer (other than officer) is based on all information of which preparer has any knowledge.
Sign Here
JumboBullet
Signature of officer Date
JumboBullet
Type or print name and title.
Paid Preparer's Use Only Preparer's
signatureBig Right Arrow 		Date
right pointing bullet image Preparer’s taxpayer identification number
(see instructions)
Firm’s name (or yours
if self-employed),
address, and ZIP + 4Big Right Arrow




 		EIN right pointing bullet image
Phone no. right pointing bullet image
May the IRS discuss this return with the preparer shown above? (see instructions) .........
For Privacy Act and Paperwork Reduction Act Notice, see the separate instructions.
Cat. No. 11282Y
Form 990 (2010)
Form 990 (2010)
Page 2
Part III
Statement of Program Service Accomplishments
Check if Schedule O contains a response to any question in this Part III . . . . . . . . . .
1
Briefly describe the organization’s mission: THE MICHAEL J. FOX FOUNDATION FOR PARKINSON'S RESEARCH IS DEDICATED TO ENSURING THE DEVELOPMENT OF BETTER TREATMENTS, AND ULTIMATELY A CURE, FOR PARKINSON'S DISEASE THROUGH AN AGRESSIVELY FUNDED RESEARCH AGENDA.
2
Did the organization undertake any significant program services during the year which were not listed on
the prior Form 990 or 990-EZ? ....................
If “Yes,” describe these new services on Schedule O.
3
Did the organization cease conducting, or make significant changes in how it conducts, any program services? ..........................
If “Yes,” describe these changes on Schedule O.
4
Describe the exempt purpose achievements for each of the organization’s three largest program services by expenses.
Section 501(c)(3) and 501(c)(4) organizations and section 4947(a)(1) trusts are required to report the amount of grants and allocations to others, the total expenses, and revenue, if any, for each program service reported.
4a (Code:   ) (Expenses $ 54,545,702 including grants of $ 49,441,852 ) (Revenue $   )
TO FUND RESEARCH FOCUSED ON DEVELOPING A CURE FOR PARKINSON'S DISEASE.
4b (Code:   ) (Expenses $   including grants of $   ) (Revenue $   )
4c (Code:   ) (Expenses $   including grants of $   ) (Revenue $   )
4d Other program services. (Describe in Schedule O.)
(Expenses $   including grants of $   ) (Revenue $   )
4e Total program service expensesMediumBullet$ 54,545,702
Form 990 (2010)
Form 990 (2010)
Page 3
Part IV
Checklist of Required Schedules
Yes
No
1
Is the organization described in section 501(c)(3) or 4947(a)(1) (other than a private foundation)? If “Yes,” complete Schedule AClick to see attachment.....................
1
Yes
 
2
Is the organization required to complete Schedule B, Schedule of Contributors? Click to see attachment........
2
Yes
 
3
Did the organization engage in direct or indirect political campaign activities on behalf of or in opposition to candidates for public office? If “Yes,” complete Schedule C, Part I..........
3
 
No
4
Section 501(c)(3) organizations. Did the organization engage in lobbying activities? If “Yes,” complete Schedule C,
Part II.........................
4
 
No
5
Is the organization a section 501(c)(4), 501(c)(5), or 501(c)(6) organization that receives membership dues, assessments, or similar amounts as defined in Revenue Procedure 98-19? If “Yes,” complete Schedule C, Part III........................
5
 
 
6
Did the organization maintain any donor advised funds or any similar funds or accounts where donors have the right to provide advice on the distribution or investment of amounts in such funds or accounts? If “Yes,” complete
Schedule D, Part IClick to see attachment.......................
6
 
No
7
Did the organization receive or hold a conservation easement, including easements to preserve open space,
the environment, historic land areas or historic structures? If “Yes,” complete Schedule D, Part IIClick to see attachment...
7
 
No
8
Did the organization maintain collections of works of art, historical treasures, or other similar assets? If “Yes,” complete Schedule D, Part III Click to see attachment....................
8
 
No
9
Did the organization report an amount in Part X, line 21; serve as a custodian for amounts not listed in Part X; or provide credit counseling, debt management, credit repair, or debt negotiation services? If “Yes,”
complete Schedule D, Part IVClick to see attachment...................
9
 
No
10
Did the organization, directly or through a related organization, hold assets in term, permanent,or quasi-endowments? If “Yes,” complete Schedule D, Part VClick to see attachment
10
 
No
11
If the organization’s answer to any of the following questions is ‘Yes,’ then complete Schedule D, Parts VI, VII, VIII, IX, or X as applicable:
a
Did the organization report an amount for land, buildings, and equipment in Part X, line10? If “Yes,” complete Schedule D, Part VI.Click to see attachment
11a
Yes
 
b
Did the organization report an amount for investments—other securities in Part X, line 12 that is 5% or more of its total assets reported in Part X, line 16? If “Yes,” complete Schedule D, Part VII.Click to see attachment
11b
 
No
c
Did the organization report an amount for investments—program related in Part X, line 13 that is 5% or more of its total assets reported in Part X, line 16? If “Yes,” complete Schedule D, Part VIII.Click to see attachment
11c
 
No
d
Did the organization report an amount for other assets in Part X, line 15 that is 5% or more of its total assets reported in Part X, line 16? If “Yes,” complete Schedule D, Part IX.Click to see attachment
11d
 
No
e
Did the organization report an amount for other liabilities in Part X, line 25? If “Yes,” complete Schedule D, Part X.Click to see attachment
11e
Yes
 
f
Did the organization’s separate or consolidated financial statements for the tax year include a footnote that addresses the organization’s liability for uncertain tax positions under FIN 48 (ASC 740)? If “Yes,” complete Schedule D, Part X.Click to see attachment
11f
Yes
 
12a
Did the organization obtain separate, independent audited financial statements for the tax year? If “Yes,” complete Schedule D, Parts XI, XII, and XIII Click to see attachment
12a
 
No
b
Was the organization included in consolidated, independent audited financial statements for the tax year? If “Yes,” and if the organization answered ‘No’ to line 12a, then completing Schedule D, Parts XI, XII, and XIII is optional Click to see attachment
12b
Yes
 
13
Is the organization a school described in section 170(b)(1)(A)(ii)? If “Yes,” complete Schedule E
13
 
No
14a
Did the organization maintain an office, employees, or agents outside of the United States?....
14a
Yes
 
b
Did the organization have aggregate revenues or expenses of more than $10,000 from grantmaking, fundraising, business, and program service activities outside the United States? If “Yes,” complete Schedule F, Part I......... Click to see attachment
14b
Yes
 
15
Did the organization report on Part IX, column (A), line 3, more than $5,000 of grants or assistance to any organization or entity located outside the U.S.? If “Yes,” complete Schedule F, Part II.. Click to see attachment
15
Yes
 
16
Did the organization report on Part IX, column (A), line 3, more than $5,000 of aggregate grants or assistance to individuals located outside the U.S.? If “Yes,” complete Schedule F, Part III.. Click to see attachment
16
Yes
 
17
Did the organization report a total of more than $15,000, of expenses for professional fundraising services on Part IX, column (A), lines 6 and 11e? If “Yes,” complete Schedule G, Part IClick to see attachment
17
Yes
 
18
Did the organization report more than $15,000 total of fundraising event gross income and contributions on Part VIII, lines 1c and 8a? If “Yes,” complete Schedule G, Part II.......... Click to see attachment
18
Yes
 
19
Did the organization report more than $15,000 of gross income from gaming activities on Part VIII, line 9a? If “Yes,” complete Schedule G, Part III................... Click to see attachment
19
 
No
Form 990 (2010)
Form 990 (2010)
Page 4
Part IV
Checklist of Required Schedules (continued)
20a
Did the organization operate one or more hospitals? If “Yes,” complete Schedule H.....
20a
 
No
b
Did the organization attach its audited financial statement to this return? Note: All Form 990 filers that operate one or more hospitals must attach audited financial statements. .....
20b
 
 
21
Did the organization report more than $5,000 of grants and other assistance to governments and organizations in the United States on Part IX, column (A), line 1? If “Yes,” complete Schedule I, Parts I and II.. Click to see attachment
21
Yes
 
22
Did the organization report more than $5,000 of grants and other assistance to individuals in the United States on Part IX, column (A), line 2? If “Yes,” complete Schedule I, Parts I and III..... Click to see attachment
22
Yes
 
23
Did the organization answer “Yes” to Part VII, Section A, questions 3, 4, or 5, about compensation of the organization’s current and former officers, directors, trustees, key employees, and highest compensated employees? If “Yes,” complete Schedule J................ Click to see attachment
23
Yes
 
24a
Did the organization have a tax-exempt bond issue with an outstanding principal amount of more than $100,000 as of the last day of the year, that was issued after December 31, 2002? If “Yes,” answer questions 24b–24d and complete Schedule K. If “No,” go to line 25................
24a
 
No
b
Did the organization invest any proceeds of tax-exempt bonds beyond a temporary period exception?...
24b
 
 
c
Did the organization maintain an escrow account other than a refunding escrow at any time during the year
to defease any tax-exempt bonds?......................
24c
 
 
d
Did the organization act as an “on behalf of” issuer for bonds outstanding at any time during the year?...
24d
 
 
25a
Section 501(c)(3) and 501(c)(4) organizations. Did the organization engage in an excess benefit transaction with a disqualified person during the year? If “Yes,” complete Schedule L, Part I...... Click to see attachment
25a
 
No
b
Is the organization aware that it engaged in an excess benefit transaction with a disqualified person in a prior year, and that the transaction has not been reported on any of the organization’s prior Forms 990 or 990-EZ? If “Yes,” complete Schedule L, Part I................ Click to see attachment
25b
 
No
26
Was a loan to or by a current or former officer, director, trustee, key employee, highly compensated employee, or disqualified person outstanding as of the end of the organization’s tax year? If “Yes,” complete Schedule L,
Part II........................... Click to see attachment
26
 
No
27
Did the organization provide a grant or other assistance to an officer, director, trustee, key employee, substantial contributor, or a grant selection committee member, or to a person related to such an individual? If “Yes,” complete Schedule L, Part III............... Click to see attachment
27
 
No
28
Was the organization a party to a business transaction with one of the following parties? (see Schedule L, Part IV instructions for applicable filing thresholds, conditions, and exceptions):
a
A current or former officer, director, trustee, or key employee? If “Yes,” complete Schedule L, Part IV ......................... Click to see attachment
28a
 
No
b
A family member of a current or former officer, director, trustee, or key employee? If “Yes,”
complete Schedule L, Part IV................... Click to see attachment
28b
 
No
c
An entity of which a current or former officer, director, trustee, or key employee (or a family member thereof) was an officer, director, trustee, or owner? If “Yes,” complete Schedule L, Part IV.. Click to see attachment
28c
Yes
 
29
Did the organization receive more than $25,000 in non-cash contributions? If “Yes,” complete Schedule MClick to see attachment
29
Yes
 
30
Did the organization receive contributions of art, historical treasures, or other similar assets, or qualified conservation contributions? If “Yes,” complete Schedule M............ Click to see attachment
30
 
No
31
Did the organization liquidate, terminate, or dissolve and cease operations? If “Yes,” complete Schedule N,
Part I........................... Click to see attachment
31
 
No
32
Did the organization sell, exchange, dispose of, or transfer more than 25% of its net assets? If “Yes,” complete Schedule N, Part II.......................
32
 
No
33
Did the organization own 100% of an entity disregarded as separate from the organization under Regulations sections 301.7701-2 and 301.7701-3? If “Yes,” complete Schedule R, Part I........ Click to see attachment
33
 
No
34
Was the organization related to any tax-exempt or taxable entity? If “Yes,” complete Schedule R, Parts II, III, IV, and V, line 1..................... Click to see attachment
34
Yes
 
35
Is any related organization a controlled entity within the meaning of section 512(b)(13)? .....
35
 
No
a
Did the organization receive any payment from or engage in any transaction with a controlled entity within the meaning of section 512(b)(13)? If “Yes,” complete Schedule R, Part V, line 2... Click to see attachment
36
Section 501(c)(3) organizations. Did the organization make any transfers to an exempt non-charitable related organization? If “Yes,” complete Schedule R, Part V, line 2........... Click to see attachment
36
 
No
37
Did the organization conduct more than 5% of its activities through an entity that is not a related organization and that is treated as a partnership for federal income tax purposes? If “Yes,” complete Schedule R, Part VIClick to see attachment
37
 
No
38
Did the organization complete Schedule O and provide explanations in Schedule O for Part VI, lines 11 and 19? Note. All Form 990 filers are required to complete Schedule O. ............
38
Yes
 
Form 990 (2010)
Form 990 (2010)
Page 5
Part V
Statements Regarding Other IRS Filings and Tax Compliance
Check if Schedule O contains a response to any question in this Part V . . . . . . . . . .
Yes
No
1a
Enter the number reported in Box 3 of Form 1096. Enter -0- if not applicable. .......
1a
109
b
Enter the number of Forms W-2G included in line 1a. Enter -0- if not applicable.
1b
0
c
Did the organization comply with backup withholding rules for reportable payments to vendors and reportable gaming (gambling) winnings to prize winners? ..................
1c
Yes
 
2a
Enter the number of employees reported on Form W-3, Transmittal of Wage and Tax Statements filed for the calendar year ending with or within the year covered by this return .....................
2a
68
b
If at least one is reported on line 2a, did the organization file all required federal employment tax returns?

Note. If the sum of lines 1a and 2a is greater than 250, you may be required to e-file. (see instructions)
2b
Yes
 
3a
Did the organization have unrelated business gross income of $1,000 or more during the year?.............................
3a
Yes
 
b
If “Yes,” has it filed a Form 990-T for this year? If “No,” provide an explanation in Schedule O.....
3b
Yes
 
4a
At any time during the calendar year, did the organization have an interest in, or a signature or other authority over, a financial account in a foreign country (such as a bank account or securities account)?.......................
4a
Yes
 
b
If "Yes," enter the name of the foreign country: MediumBulletCA
See instructions for filing requirements for Form TD F 90-22.1, Report of Foreign Bank and Financial Accounts.
5a
Was the organization a party to a prohibited tax shelter transaction at any time during the tax year?..
5a
 
No
b
Did any taxable party notify the organization that it was or is a party to a prohibited tax shelter transaction?
5b
 
No
c
If “Yes” to line 5a or 5b, did the organization file Form 8886-T? ........
5c
 
 
6a
Does the organization have annual gross receipts that are normally greater than $100,000, and did the organization solicit any contributions that were not tax deductible?..........
6a
 
No
b
If “Yes,” did the organization include with every solicitation an express statement that such contributions or gifts were not tax deductible?........................
6b
 
 
7
Organizations that may receive deductible contributions under section 170(c).
a
Did the organization receive a payment in excess of $75 made partly as a contribution and partly for goods and services provided to the payor?....................
7a
Yes
 
b
If “Yes,” did the organization notify the donor of the value of the goods or services provided?.....
7b
Yes
 
c
Did the organization sell, exchange, or otherwise dispose of tangible personal property for which it was required to file Form 8282?...........................
7c
 
No
d
If “Yes,” indicate the number of Forms 8282 filed during the year ....
7d
 
e
Did the organization receive any funds, directly or indirectly, to pay premiums on a personal benefit contract?..........................
7e
 
No
f
Did the organization, during the year, pay premiums, directly or indirectly, on a personal benefit contract?..
7f
 
No
g
If the organization received a contribution of qualified intellectual property, did the organization file Form 8899 as required?...................
7g
 
 
h
If the organization received a contribution of cars, boats, airplanes, or other vehicles, did the organization file a Form 1098-C?...............
7h
 
 
8
Sponsoring organizations maintaining donor advised funds and section 509(a)(3) supporting organizations. Did the supporting organization, or a donor advised fund maintained by a sponsoring organization, have excess business holdings at any time during the year?................
8
 
 
9
Sponsoring organizations maintaining donor advised funds.
a
Did the organization make any taxable distributions under section 4966?.........
9a
 
 
b
Did the organization make a distribution to a donor, donor advisor, or related person?......
9b
 
 
10
Section 501(c)(7) organizations. Enter:
a
Initiation fees and capital contributions included on Part VIII, line 12 ...
10a
 
b
Gross receipts, included on Form 990, Part VIII, line 12, for public use of club facilities
10b
 
11
Section 501(c)(12) organizations. Enter:
a
Gross income from members or shareholders .........
11a
 
b
Gross income from other sources (Do not net amounts due or paid to other sources against amounts due or received from them.) ........
11b
 
12a
Section 4947(a)(1) non-exempt charitable trusts. Is the organization filing Form 990 in lieu of Form 1041?
12a
 
 
b
If “Yes,” enter the amount of tax-exempt interest received or accrued during the year.
12b
 
13
Section 501(c)(29) qualified nonprofit health insurance issuers.
a
Is the organization licensed to issue qualified health plans in more than one state?
Note. All 501(c)(29) organizations must list in Schedule O each state in which they are licensed to issue qualified health plans, the amount of reserves required by each state, and the amount of reserves the organization allocated to each state.
13a
 
 
b
Enter the aggregate amount of reserves the organization is required to maintain by the states in which the organization is licensed to issue qualified health plans.
13b
 
c
Enter the aggregate amount of reserves on hand.
13c
 
14a
Did the organization receive any payments for indoor tanning services during the tax year?.....
14a
 
 
b
If "Yes," has it filed a Form 720 to report these payments? If “No,” provide an explanation in Schedule O..
14b
 
 
Form 990 (2010)
Form 990 (2010)
Page 6
Part VI
Governance, Management, and Disclosure For each “Yes” response to lines 2 through 7b below, and for a “No” response to lines 8a, 8b, or 10b below, describe the circumstances, processes, or changes in Schedule O. See instructions.
Check if Schedule O contains a response to any question in this Part VI . . . . . . . . . .
Section A. Governing Body and Management
Yes
No
1a
Enter the number of voting members of the governing body at the end of the tax year ..............
1a
26
b
Enter the number of voting members included in line 1a, above, who are independent .................
1b
24
2
Did any officer, director, trustee, or key employee have a family relationship or a business relationship with any other officer, director, trustee, or key employee? .................
2
Yes
 
3
Did the organization delegate control over management duties customarily performed by or under the direct supervision of officers, directors or trustees, or key employees to a management company or other person? ..
3
 
No
4
Did the organization make any significant changes to its governing documents since the prior Form 990 was filed?
4
 
No
5
Did the organization become aware during the year of a significant diversion of the organization’s assets? .
5
 
No
6
Does the organization have members or stockholders? ................
6
 
No
7a
Does the organization have members, stockholders, or other persons who may elect one or more members of the governing body? .........................
7a
 
No
b
Are any decisions of the governing body subject to approval by members, stockholders, or other persons? ..
7b
 
No
8
Did the organization contemporaneously document the meetings held or written actions undertaken during the year by the following:
a
The governing body? .........................
8a
Yes
 
b
Each committee with authority to act on behalf of the governing body? ............
8b
Yes
 
9
Is there any officer, director, trustee, or key employee listed in Part VII, Section A, who cannot be reached at the organization’s mailing address? If “Yes,” provide the names and addresses in Schedule O .....
9
 
No
Section B. Policies (This Section B requests information about policies not required by the Internal
Revenue Code.)
Yes
No
10a
Does the organization have local chapters, branches, or affiliates? ............
10a
 
No
b
If “Yes,” does the organization have written policies and procedures governing the activities of such chapters, affiliates, and branches to ensure their operations are consistent with those of the organization? ....
10b
 
 
11a
Has the organization provided a copy of this Form 990 to all members of its governing body before filing the form?
11a
Yes
 
b
Describe in Schedule O the process, if any, used by the organization to review the Form 990. .....
12a
Does the organization have a written conflict of interest policy? If “No,” go to line 13.......
12a
Yes
 
b
Are officers, directors or trustees, and key employees required to disclose annually interests that could give rise to conflicts? ...........................
12b
Yes
 
c
Does the organization regularly and consistently monitor and enforce compliance with the policy? If “Yes,” describe in Schedule O how this is done ....................
12c
Yes
 
13
Does the organization have a written whistleblower policy? ...............
13
Yes
 
14
Does the organization have a written document retention and destruction policy? .........
14
Yes
 
15
Did the process for determining compensation of the following persons include a review and approval by independent persons, comparability data, and contemporaneous substantiation of the deliberation and decision?
a
The organization’s CEO, Executive Director, or top management official ...........
15a
Yes
 
b
Other officers or key employees of the organization ................
15b
Yes
 
If "Yes" to line a or b, describe the process in Schedule O. (See instructions.)
16a
Did the organization invest in, contribute assets to, or participate in a joint venture or similar arrangement with a taxable entity during the year? ......................
16a
 
No
b
If “Yes,” has the organization adopted a written policy or procedure requiring the organization to evaluate its participation in joint venture arrangements under applicable federal tax law, and taken steps to safeguard the organization’s exempt status with respect to such arrangements? ............
16b
 
 
Section C. Disclosure
17
List the States with which a copy of this Form 990 is required to be filedMediumBullet
AL , AK , AZ , AR , CA , CO , CT , FL , GA , IL , KS , KY , ME , MD , MA , MI , MN , MS , NH , NJ , NM , NY , NC , ND , OH , OK , OR , PA , RI , SC , TN , UT , VA , WA , WV , WI
18
Section 6104 requires an organization to make its Form 1023 (or 1024 if applicable), 990, and 990-T (501(c)(3)s only) available for public inspection. Indicate how you make these available. Check all that apply.
19
Describe in Schedule O whether (and if so, how), the organization makes its governing documents, conflict of interest policy, and financial statements available to the public.
20
State the name, physical address, and telephone number of the person who possesses the books and records of the organization: MediumBullet
JOANNE MARTZ
CHURCH STREET STATION PO BOX 780
NEW YORK,NY100080780
(212) 509-0995
Form 990 (2010)
Form 990 (2010)
Page 7
Part VII
Compensation of Officers, Directors,Trustees, Key Employees, Highest Compensated Employees, and Independent Contractors
Check if Schedule O contains a response to any question in this Part VII . . . . . . . . . .
Section A. Officers, Directors, Trustees, Key Employees, and Highest Compensated Employees
1a Complete this table for all persons required to be listed. Report compensation for the calendar year ending with or within the organization’s tax year.
RoundBullet List all of the organization’s current officers, directors, trustees (whether individuals or organizations), regardless of amount
of compensation, and current key employees. Enter -0- in columns (D), (E), and (F) if no compensation was paid.

RoundBullet List all of the organization’s current key employees, if any. See instructions for definition of "key employee."
RoundBullet List the organization’s five current highest compensated employees (other than an officer, director, trustee or key employee)
who received reportable compensation (Box 5 of Form W-2 and/or Box 7 of Form 1099-MISC) of more than $100,000 from the
organization and any related organizations.

RoundBullet List all of the organization’s former officers, key employees, or highest compensated employees who received more than $100,000
of reportable compensation from the organization and any related organizations.

RoundBullet List all of the organization’s former directors or trustees that received, in the capacity as a former director or trustee of the
organization, more than $10,000 of reportable compensation from the organization and any related organizations.

List persons in the following order: individual trustees or directors; institutional trustees; officers; key employees; highest
compensated employees; and former such persons.
Check this box if neither the organization nor any related organizations compensated any current or former officer, director, or trustee.
(A)
Name and Title 		(B)
Average hours per week (describe hours for related organizations in Schedule O) 		(C)
Position (check all that apply) 		(D)
Reportable compensation from the organization (W- 2/1099-MISC) 		(E)
Reportable compensation from related organizations (W- 2/1099-MISC) 		(F)
Estimated amount of other compensation from the organization and related organizations
Individual Trustee or Director; Institutional Trustee; Officer; Key Employee; Highest compensated employee; Former;
(1) MICHAEL J FOX
FOUNDER
 2.0 X           0 0 0
(2) HOLLY S ANDERSEN MD
MEMBER
 2.0 X           0 0 0
(3) EVA ANDERSSON-DUBIN MD
MEMBER
 2.0 X           0 0 0
(4) JON BROOKS
MEMBER
 2.0 X           0 0 0
(5) BARRY COHEN
MEMBER
 2.0 X           0 0 0
(6) DONNY DEUTSCH
MEMBER
 2.0 X           0 0 0
(7) DAVID EINHORN
MEMBER
 2.0 X           0 0 0
(8) KAREN FINERMAN
MEMBER
 2.0 X           0 0 0
(9) NELLE FORTENBERRY
MEMBER
 2.0 X           0 0 0
(10) ALBERT B GLICKMAN
MEMBER
 2.0 X           0 0 0
(11) DAVID GOLUB
VICE CHAIRMAN
 2.0 X   X       0 0 0
(12) MARK L HART III
MEMBER
 2.0 X           0 0 0
(13) KATHLEEN KENNEDY
MEMBER
 2.0 X           0 0 0
(14) MORTON M KONDRACKE
MEMBER
 2.0 X           0 0 0
(15) EDWIN A LEVY
MEMBER
 2.0 X           0 0 0
(16) SKIP IRVING
MEMBER
 2.0 X           0 0 0
(17) MARC S LIPSCHULTZ
MEMBER
 2.0 X           0 0 0
Form 990 (2010)
Form 990 (2010)
Page 8
Part VII
Section A. Officers, Directors, Trustees, Key Employees, and Highest Compensated Employees (continued)
(A)
Name and Title 		(B)
Average hours per week (describe hours for related organizations in Schedule O) 		(C)
Position (check all that apply) 		(D)
Reportable compensation from the organization (W- 2/1099-MISC) 		(E)
Reportable compensation from related organizations (W- 2/1099-MISC) 		(F)
Estimated amount of other compensation from the organization and related organizations
Individual Trustee or Director; Institutional Trustee; Officer; Key Employee; Highest compensated employee; Former;
(18) TRACY POLLAN
MEMBER
 2.0 X           0 0 0
(19) DOUGLAS I OSTROVER
MEMBER
 2.0 X           0 0 0
(20) GEORGE E PRESCOTT
CHAIRMAN
 2.0 X   X       0 0 0
(21) LILY SAFRA
MEMBER
 2.0 X           0 0 0
(22) CURTIS SCHENKER
MEMBER
 2.0 X           0 0 0
(23) FREDRICK E ROWE JR
MEMBER
 2.0 X           0 0 0
(24) RYAN REYNOLDS
MEMBER
 2.0 X           0 0 0
(25) FRED G WEISS
MEMBER
 2.0 X           0 0 0
(26) ROBERT W SHACKLETON
MEMBER
 2.0 X           0 0 0
(27) KATHERINE H HOOD
CEO
 40.0     X       470,623 0 7,753
(28) JOANNE MARTZ
CHIEF FIN/ADMIN OFFICER
 40.0     X       225,396 0 19,335
(29) Todd Sherer
CHIEF PROGRAM OFFICER
 40.0     X       325,496 0 19,923
(30) KAREN LEIES
vp Development
 40.0       X     222,125 0 24,491
(31) DEBORAH W BROOKS
CO-FOUNDER
 40.0       X     440,606 0 25,177
(32) John T Grant
Controller
 40.0         X   145,796 0 10,189
(33) SHEILA KELLY
DIR. SPECIAL EVENTS & TEAM FOX
 40.0         X   146,287 0 10,164
(34) Brian K Fiske
Associate Director
 40.0         X   142,653 0 16,626
(35) Sohini Chowdhury
Associate Director
 40.0         X   136,265 0 9,863
(36) JAMIE L EBERLING
ASSOCIATE DIRECTOR
 40.0         X   119,754 0 9,368
1b Sub-Total................MediumBullet
c Total from continuation sheets to Part VII, Section A....MediumBullet
d Total (add lines 1b and 1c)............MediumBullet 2,375,001 0 152,889
2
Total number of individuals (including but not limited to those listed above) who received more than $100,000 in reportable compensation from the organizationMediumBullet13
Yes
No
3
Did the organization list any former officer, director or trustee, key employee, or highest compensated employee on line 1a? If “Yes,” complete Schedule J for such individual .............
3
 
No
4
For any individual listed on line 1a, is the sum of reportable compensation and other compensation from the organization and related organizations greater than $150,000? If “Yes,” complete Schedule J for such individual...........................
4
Yes
 
5
Did any person listed on line 1a receive or accrue compensation from any unrelated organization or individual for services rendered to the organization? If “Yes,” complete Schedule J for such person .....
5
 
No
Section B. Independent Contractors
1
Complete this table for your five highest compensated independent contractors that received more than $100,000 of compensation from the organization.
(A)
Name and business address 		(B)
Description of services 		(C)
Compensation
SCHANER AND LUBITZ LLC
6391 ARLINGTIN ROAD SUITE 200
BETHESDA,MD20814 		Legal Advice 169,100
2
Total number of independent contractors (including but not limited to those listed above) who received more than $100,000 in compensation from the organization MediumBullet1
Form 990 (2010)
Form 990 (2010)
Page 9
Part VIII
Statement of Revenue
(A)
Total revenue 		(B)
Related or
exempt
function
revenue 		(C)
Unrelated
business
revenue 		(D)
Revenue
excluded from
tax under sections
512, 513, or 514
Contributions, gifts, grants and other similar amounts 1a Federated campaigns..1a  
b Membership dues....1b  
c Fundraising events....1c 6,988,278
d Related organizations...1d 180,240
e Government grants (contributions)1e  
f All other contributions, gifts, grants, and
similar amounts not included above1f 		49,942,588
g Noncash contributions included in lines 1a-1f:$ 5,398,435
h Total. Add lines 1a-1f.......MediumBullet 57,111,106
Program Service Revenue Business Code
2a
b
c
d
e
f All other program service revenue .        
g Total. Add lines 2a–2f........MediumBullet 0
Other Revenue 3 Investment income (including dividends, interest
and other similar amounts).....MediumBullet 232,554     232,554
4 Income from investment of tax-exempt bond proceeds..MediumBullet 0      
5 Royalties............MediumBullet 0      
(i) Real (ii) Personal
6a Gross Rents    
b Less: rental expenses    
c Rental income or (loss)    
d Net rental income or (loss).......MediumBullet        
(i) Securities (ii) Other
7a Gross amount from sales of assets other than inventory 48,484,078  
b Less: cost or other basis and sales expenses 48,240,455  
c Gain or (loss) 243,623  
d Net gain or (loss)..........MediumBullet 243,623     243,623
8a Gross income from fundraising events (not including
$ 6,988,278
of contributions reported on line 1c). See Part IV, line 18 ...
a 358,540
b Less: direct expenses ...b 358,540
c Net income or (loss) from fundraising events..MediumBullet 0    
9a Gross income from gaming activities.
See Part IV, line 19 ...
a  
b Less: direct expenses ...b  
c Net income or (loss) from gaming activities...MediumBullet 0      
10a Gross sales of inventory, less
returns and allowances .
a 63,633
b Less: cost of goods sold ..b 35,140
c Net income or (loss) from sales of inventory..MediumBullet 28,493   28,493  
Miscellaneous Revenue Business Code
11a MISCELLANEOUS REVENUE   5,684     5,684
b            
c            
d All other revenue ....        
e Total. Add lines 11a–11d ......MediumBullet 5,684
12 Total revenue. See Instructions....MediumBullet 57,621,460   28,493 481,861
Form 990 (2010)
Form 990 (2010)
Page 10
Part IX
Statement of Functional Expenses
Section 501(c)(3) and 501(c)(4) organizations must complete all columns. All other organizations must complete column (A) but are not required to complete columns (B), (C), and (D).
Do not include amounts reported on lines 6b,
7b, 8b, 9b, and 10b of Part VIII. 		(A)
Total expenses 		(B)
Program service expenses 		(C)
Management and general expenses 		(D)
Fundraising expenses
1 Grants and other assistance to governments and organizations in the U.S. See Part IV, line 21 32,651,054 32,651,054
2 Grants and other assistance to individuals in the U.S. See Part IV, line 22 0  
3 Grants and other assistance to governments, organizations, and individuals outside the U.S. See Part IV, lines 15 and 16 16,790,797 16,790,797
4 Benefits paid to or for members 0  
5 Compensation of current officers, directors, trustees, and key employees .... 1,773,646 398,838 386,060 988,748
6 Compensation not included above, to disqualified persons (as defined under section 4958(f)(1)) and persons described in section 4958(c)(3)(B) .... 0      
7 Other salaries and wages 3,536,349 2,309,989 504,014 722,346
8 Pension plan contributions (include section 401(k) and section 403(b) employer contributions) .... 103,054 60,866 14,136 28,052
9 Other employee benefits ....... 342,782 175,679 71,459 95,644
10 Payroll taxes ........... 351,224 177,956 58,497 114,771
11 Fees for services (non-employees):        
a Management ...... 0      
b Legal ......... 127,049 118,500 1,500 7,049
c Accounting ........... 48,078   48,078  
d Lobbying ........... 0      
e Professional fundraising. See Part IV, line 17.. 49,600 49,600
f Investment management fees ...... 0      
g Other .......... 257,571 48,905 81,226 127,440
12 Advertising and promotion .... 144,442 37,849   106,593
13 Office expenses ....... 506,088 200,590 20,646 284,852
14 Information technology ...... 194,155 96,116 25,303 72,736
15 Royalties .. 0      
16 Occupancy ........... 487,401 264,351 67,707 155,343
17 Travel ............ 158,746 33,997 4,585 120,164
18 Payments of travel or entertainment expenses for any federal, state, or local public officials ...... 0      
19 Conferences, conventions, and meetings .... 1,166,889 1,041,364 4,671 120,854
20 Interest ........... 48,548   48,548  
21 Payments to affiliates ....... 0      
22 Depreciation, depletion, and amortization ..... 132,259 68,422 22,031 41,806
23 Insurance .............. 53,876 42,837 3,225 7,814
24 Other expenses. Itemize expenses not covered above. (Expenses grouped together and labeled miscellaneous may not exceed 5% of total expenses shown on line 25 below.)
a CREDIT CARD & BROKERAGE FEES 186,625     186,625
b OTHER SPECIAL EVENTS EXPENSE 681,038     681,038
c DONATION PROCESSING 94,951     94,951
d MARATHON RUNNER FEES 101,964     101,964
e DUES AND SUBSCRIPTIONS 38,693 22,535 6,607 9,551
f All other expenses 29,665 5,057 4,985 19,623
25 Total functional expenses. Add lines 1 through 24f 60,056,544 54,545,702 1,373,278 4,137,564
26 Joint costs. Check here MediumBullet if following
SOP 98-2 (ASC 958-720). Complete this line only if the organization reported in column (B) joint costs from a combined educational campaign and fundraising solicitation 		       
Form 990 (2010)
Form 990 (2010)
Page 11
Part X Balance Sheet
(A)
Beginning of year 		(B)
End of year
Assets 1 Cash—non-interest-bearing .......... 4,579 1 1,724
2 Savings and temporary cash investments ....... 16,253,619 2 47,584,331
3 Pledges and grants receivable, net ......... 35,167,945 3 28,467,039
4 Accounts receivable, net .........   4  
5 Receivables from current and former officers, directors, trustees, key employees, and highest compensated employees. Complete Part II of
Schedule L ..........   5  
6 Receivables from other disqualified persons (as defined under section 4958(f)(1)) and persons described in section 4958(c)(3)(B). Complete Part II of
Schedule L ..........   6  
7 Notes and loans receivable, net .............   7  
8 Inventories for sale or use .............. 28,036 8 22,872
9 Prepaid expenses and deferred charges ............ 156,687 9 310,926
10a Land, buildings, and equipment: cost or other basis. Complete Part VI of Schedule D 10a 1,220,999
b Less: accumulated depreciation. ..... 10b 883,939 278,893 10c 337,060
11 Investments—publicly traded securities .......... 17,091,145 11 1,467,886
12 Investments—other securities. See Part IV, line 11 ......   12  
13 Investments—program-related. See Part IV, line 11 ..   13  
14 Intangible assets .........   14  
15 Other assets. See Part IV, line 11 ........... 33,061 15 33,061
16 Total assets. Add lines 1 through 15 (must equal line 34)... 69,013,965 16 78,224,899
Liabilities 17 Accounts payable and accrued expenses . 1,768,622 17 1,542,594
18 Grants payable .......... 41,763,613 18 53,453,069
19 Deferred revenue ..........   19  
20 Tax-exempt bond liabilities ..........   20  
21 Escrow or custodial account liability. Complete Part IV of Schedule D..   21  
22 Payables to current and former officers, directors, trustees, key
employees, highest compensated employees, and disqualified
persons. Complete Part II of Schedule L..........   22  
23 Secured mortgages and notes payable to unrelated third parties ..   23  
24 Unsecured notes and loans payable to unrelated third parties .... 1,000,196 24 1,000,196
25 Other liabilities. Complete Part X of Schedule D..... 453,533 25 626,588
26 Total liabilities. Add lines 17 through 25..... 44,985,964 26 56,622,447
Net Assets or Fund Balance Organizations that follow SFAS 117, check here MediumBullet and complete lines 27 through 29, and lines 33 and 34.
27 Unrestricted net assets ..... 2,345,986 27 4,194,131
28 Temporarily restricted net assets ..... 21,682,015 28 17,408,321
29 Permanently restricted net assets .....   29  
Organizations that do not follow SFAS 117, check here MediumBullet and complete lines 30 through 34.
30 Capital stock or trust principal, or current funds .....   30  
31 Paid-in or capital surplus, or land, building or equipment fund .....   31  
32 Retained earnings, endowment, accumulated income, or other funds   32  
33 Total net assets or fund balances ..... 24,028,001 33 21,602,452
34 Total liabilities and net assets/fund balances ..... 69,013,965 34 78,224,899
Form 990 (2010)
Form 990 (2010)
Page 12
Part XI
Reconcilliation of Net Assets
Check if Schedule O contains a response to any question in this Part XI . . . . . . . . . .
1
Total revenue (must equal Part VIII, column (A), line 12) . . .
1
57,621,460
2
Total expenses (must equal Part IX, column (A), line 25) . . . . .
2
60,056,544
3
Revenue less expenses. Subtract line 2 from line 1 . . . .
3
-2,435,084
4
Net assets or fund balances at beginning of year (must equal Part X, line 33, column (A)) . .
4
24,028,001
5
Other changes in net assets or fund balances (explain in Schedule O) . . . .
5
9,535
6
Net assets or fund balances at end of year. Combine lines 3, 4, and 5 (must equal Part X, line 33, column (B)) . . . . . .
6
21,602,452
Part XII
Financial Statements and Reporting
Check if Schedule O contains a response to any question in this Part XII . . . . . . . . . .
Yes
No
1
Accounting method used to prepare the Form 990:  
If the organization changed its method of accounting from a prior year or checked "Other," explain in
Schedule O.
2a
Were the organization’s financial statements compiled or reviewed by an independent accountant?..
2a
 
No
b
Were the organization’s financial statements audited by an independent accountant?........
2b
Yes
 
c
If “Yes,” to 2a or 2b, does the organization have a committee that assumes responsibility for oversight of the audit, review, or compilation of its financial statements and selection of an independent accountant?
If the organization changed either its oversight process or selection process during the tax year, explain in Schedule O............................
2c
Yes
 
d
If “Yes” to line 2a or 2b, check a box below to indicate whether the financial statements for the year were issued on a separate basis, consolidated basis, or both:
3a
As a result of a federal award, was the organization required to undergo an audit or audits as set forth in the Single Audit Act and OMB Circular A-133? ................
3a
 
No
b
If “Yes,” did the organization undergo the required audit or audits? If the organization did not undergo the required audit or audits, explain why in Schedule O and describe any steps taken to undergo such audits. ..
3b
 
 
Form 990 (2010)
Additional Data


Software ID:  
Software Version:  
Form 990, Special Condition Description:
Special Condition Description
SCHEDULE A
(Form 990 or 990EZ)

Department of the Treasury
Internal Revenue Service
Public Charity Status and Public Support

Complete if the organization is a section 501(c)(3) organization or a section
4947(a)(1) nonexempt charitable trust.
right arrow Attach to Form 990 or Form 990-EZ. right arrow See separate instructions.
OMB No. 1545-0047
2010
Open to Public
Inspection
Name of the organization
The Michael J Fox Foundation
FOR PARKINSON'S RESEARCH
Employer identification number

13-4141945
Part I
Reason for Public Charity Status (All organizations must complete this part.) See instructions
The organization is not a private foundation because it is: (For lines 1 through 11, check only one box.)
1
2
3
4
5
section 170(b)(1)(A)(iv). (Complete Part II.)
6
7
8
9
receipts from activities related to its exempt functions—subject to certain exceptions, and (2) no more than 331/3% of
its support from gross investment income and unrelated business taxable income (less section 511 tax) from businesses
acquired by the organization after June 30, 1975. See section 509(a)(2). (Complete Part III.)
10
11
e
f
g
(i) a person who directly or indirectly controls, either alone or together with persons described in (ii)
Yes
No
and (iii) below, the governing body of the the supported organization? ................
11g(i)
 
 
(ii) a family member of a person described in (i) above? ......................
11g(ii)
 
 
(iii) a 35% controlled entity of a person described in (i) or (ii) above? ................
11g(iii)
 
 
h
(i)
Name of supported organization 		(ii)
EIN 		(iii)
Type of organization (described on lines 1- 9 above or IRC section (see instructions)) 		(iv)
Is the organization in col. (i) listed in your governing document? 		(v)
Did you notify the organization in col. (i) of your support? 		(vi)
Is the organization in col. (i) organized in the U.S.? 		(vii)
Amount of support?
Yes No Yes No Yes No
Total                  

For Paperwork Reduction Act Notice, see the Instructions for Form 990.
Cat. No. 11285F
Schedule A (Form 990 or 990-EZ) 2010
Schedule A (Form 990 or 990-EZ) 2010
Page 2
Part II
Support Schedule for Organizations Described in IRC 170(b)(1)(A)(iv) and 170(b)(1)(A)(vi)
(Complete only if you checked the box on line 5, 7, or 8 of Part I or if the organization failed to qualify under Part III. If the organization fails to qualify under the tests listed below, please complete Part III.)
Section A. Public Support
Calendar year(or fiscal year beginning in) (a) 2006 (b) 2007 (c) 2008 (d) 2009 (e) 2010 (f) Total
1 Gifts, grants, contributions, and membership fees received. (Do not include any "unusual grants.") .... 31,063,349 37,700,456 42,077,867 51,259,577 57,125,384 219,226,633
2 Tax revenues levied for the organization's benefit and either paid to or expended on its behalf.......            
3 The value of services or facilities furnished by a governmental unit to the organization without charge..            
4 Total. Add lines 1 through 3.. 31,063,349 37,700,456 42,077,867 51,259,577 57,125,384 219,226,633
5 The portion of total contributions by each person (other than a governmental unit or publicly supported organization) included on line 1 that exceeds 2% of the amount shown on line 11, column (f)..           75,581,258
6 Public Support. Subtract line 5 from line 4.           143,645,375
Section B. Total Support
Calendar year(or fiscal year beginning in) (a) 2006 (b) 2007 (c) 2008 (d) 2009 (e) 2010 (f) Total
7 Amounts from line 4.. 31,063,349 37,700,456 42,077,867 51,259,577 57,125,384 219,226,633
8 Gross income from interest, dividends, payments received on securities loans, rents, royalties and income from similar sources.. 393,477 764,390 744,930 157,415 232,554 2,292,766
9 Net income from unrelated business activities, whether or not the business is regularly carried on..            
10 Other income. (Explain in Part IV.) Do not include gain or loss from the sale of capital assets.. 58,519 117 25,682 15,213 34,177 133,708
11 Total support (Add lines 7 through 10).           221,653,107
12
12
 
13
Section C. Computation of Public Support Percentage
14
14
64.806 %
15
15
69.221 %
16a
b
17a
b
18
Schedule A (Form 990 or 990-EZ) 2010
Schedule A (Form 990 or 990-EZ) 2010
Page 3
Part III
Support Schedule for Organizations Described in IRC 509(a)(2)
(Complete only if you checked the box on line 9 of Part I or if the organization failed to qualify under Part II. If the organization fails to qualify under the tests listed below, please complete Part II.)
Section A. Public Support
Calendar year(or fiscal year beginning in) (a) 2006 (b) 2007 (c) 2008 (d) 2009 (e) 2010 (f) Total
1 Gifts, grants, contributions, and membership fees received. (Do not include any "unusual grants.") .            
2 Gross receipts from admissions, merchandise sold or services performed, or facilities furnished in any activity that is related to the organization's tax-exempt purpose......            
3 Gross receipts from activities that are not an unrelated trade or business under section 513..            
4 Tax revenues levied for the organization's benefit and either paid to or expended on its behalf...            
5 The value of services or facilities furnished by a governmental unit to the organization without charge..            
6 Total. Add lines 1 through 5.            
7a Amounts included on lines 1, 2, and 3 received from disqualified persons...            
b Amounts included on lines 2 and 3 received from other than disqualified persons that exceed the greater of $5,000 or 1% of the amount on line 13 for the year.            
c Add lines 7a and 7b..            
8 Public Support (Subtract line 7c from line 6.)            
Section B. Total Support
Calendar year (or fiscal year beginning in) (a) 2006 (b) 2007 (c) 2008 (d) 2009 (e) 2010 (f) Total
9 Amounts from line 6...            
10a Gross income from interest, dividends, payments received on securities loans, rents, royalties and income from similar sources..            
b Unrelated business taxable income (less section 511 taxes) from businesses acquired after June 30, 1975.            
c Add lines 10a and 10b.            
11 Net income from unrelated business activities not included in line 10b, whether or not the business is regularly carried on.            
12 Other income. Do not include gain or loss from the sale of capital assets (Explain in Part IV.)            
13 Total support (Add lines 9, 10c, 11 and 12.).            
14
Section C. Computation of Public Support Percentage
15
15
 
16
16
 
Section D. Computation of Investment Income Percentage
17
17
 
18
18
 
19a
b
20
Schedule A (Form 990 or 990-EZ) 2010
Schedule A (Form 990 or 990-EZ) 2010
Page 4
Part IV
Supplemental Information. Supplemental Information. Complete this part to provide the explanation required by Part II, line 10; Part II, line 17a or 17b; or Part III, line 12. Also complete this part for any additional information. (See instructions).
Facts And Circumstances Test
 
Explanation
 
 
 
 
Schedule A (Form 990 or 990-EZ) 2010

Additional Data


Software ID:  
Software Version:  
Schedule B
(Form 990, 990-EZ,
or 990-PF)
Department of the Treasury
Internal Revenue Service
Schedule of Contributors
Arrow Bullet Attach to Form 990, 990-EZ, or 990-PF.
OMB No. 1545-0047
2010
Name of organization
The Michael J Fox Foundation
FOR PARKINSON'S RESEARCH
Employer identification number

13-4141945
Organization type (check one):
Filers of:
Section:
Form 990 or 990-EZ





Form 990-PF




Check if your organization is covered by the General Rule or a Special Rule.  
Note. Only a section 501(c)(7), (8), or (10) organization can check boxes for both the General Rule and a Special Rule. See instructions.
General Rule—
Special Rules
......................... Arrow Bullet   $    
Caution. An Organization that is not covered by the General Rule and/or the Special Rules does not file Schedule B (Form 990,
990-EZ, or 990-PF), but it must answer “No” on Part IV, line 2 of its Form 990, or check the box in the heading of its
Form 990-EZ, or on line 2 of its Form 990-PF, to certify that it does not meet the filing requirements of Schedule B (Form 990,
990-EZ, or 990-PF).
For Paperwork Reduction Act Notice, see the Instructions
for Form 990, 990-EZ, or 990-PF.
Cat. No. 30613XSchedule B (Form 990, 990-EZ, or 990-PF) (2010)

Schedule B (Form 990, 990-EZ, or 990-PF) (2010)
Page 1 of 1 of Part I
Name of organization
The Michael J Fox Foundation
FOR PARKINSON'S RESEARCH 		Employer identification number

13-4141945
Part I
Contributors (see Instructions)
     
(a)
No.		 (b)
Name, address, and ZIP + 4		 (c)
Aggregate contributions		 (d)
Type of contribution
RESTRICTED
RESTRICTED
 

     
RESTRICTED
RESTRICTED  
RESTRICTED, RESTRICTED   RESTRICTED

$RESTRICTED




(Complete Part II if there is
a noncash contribution.)
(a)
No.		 (b)
Name, address, and ZIP + 4		 (c)
Aggregate contributions		 (d)
Type of contribution
 
 
 

     
 
   

$  




(Complete Part II if there is
a noncash contribution.)
(a)
No.		 (b)
Name, address, and ZIP + 4		 (c)
Aggregate contributions		 (d)
Type of contribution
 
 
 

     
 
   

$  




(Complete Part II if there is
a noncash contribution.)
(a)
No.		 (b)
Name, address, and ZIP + 4		 (c)
Aggregate contributions		 (d)
Type of contribution
 
 
 

     
 
   

$  




(Complete Part II if there is
a noncash contribution.)
(a)
No.		 (b)
Name, address, and ZIP + 4		 (c)
Aggregate contributions		 (d)
Type of contribution
 
 
 

     
 
   

$  




(Complete Part II if there is
a noncash contribution.)
(a)
No.		 (b)
Name, address, and ZIP + 4		 (c)
Aggregate contributions		 (d)
Type of contribution
 
 
 

     
 
   

$  




(Complete Part II if there is
a noncash contribution.)
Schedule B (Form 990, 990-EZ, or 990-PF) (2010)

Schedule B (Form 990, 990-EZ, or 990-PF) (2010)
Page 1 of 1 of Part II
Name of organization
The Michael J Fox Foundation
FOR PARKINSON'S RESEARCH 		Employer identification number

13-4141945
Part II
Noncash Property (see Instructions)
     
(a) No.
from
Part I		 (b)
Description of noncash property given		 (c)
FMV (or estimate)
(see instructions) 		(d)
Date received
 
$    
(a) No.
from
Part I		 (b)
Description of noncash property given		 (c)
FMV (or estimate)
(see instructions) 		(d)
Date received
 
$    
(a) No.
from
Part I		 (b)
Description of noncash property given		 (c)
FMV (or estimate)
(see instructions) 		(d)
Date received
 
$    
(a) No.
from
Part I		 (b)
Description of noncash property given		 (c)
FMV (or estimate)
(see instructions) 		(d)
Date received
 
$    
(a) No.
from
Part I		 (b)
Description of noncash property given		 (c)
FMV (or estimate)
(see instructions) 		(d)
Date received
 
$    
(a) No.
from
Part I		 (b)
Description of noncash property given		 (c)
FMV (or estimate)
(see instructions) 		(d)
Date received
 
$    
Schedule B (Form 990, 990-EZ, or 990-PF) (2010)

Schedule B (Form 990, 990-EZ, or 990-PF) (2010)
Page 1 of 1 of Part III
Name of organization
The Michael J Fox Foundation
FOR PARKINSON'S RESEARCH 		Employer identification number

13-4141945
Part III
Exclusively religious, charitable, etc., individual contributions to section 501(c)(7), (8), or (10) organizations
aggregating more than $1,000 for the year. (Complete columns (a) through (e) and the following line entry.)
For organizations completing Part III, enter the total of exclusively religious, charitable, etc.,
contributions of $1,000 or less for the year. (Enter this information once. See instructions.) Arrow Bullet $  
(a) No.
from
Part I		 (b)
Purpose of gift		 (c)
Use of gift		 (d)
Description of how gift is held
 
(e)
Transfer of gift
Transferee's name, address, and ZIP 4 Relationship of transferor to transferee
 
 
       
 
(a) No.
from
Part I		 (b)
Purpose of gift		 (c)
Use of gift		 (d)
Description of how gift is held
 
(e)
Transfer of gift
Transferee's name, address, and ZIP 4 Relationship of transferor to transferee
 
 
       
 
(a) No.
from
Part I		 (b)
Purpose of gift		 (c)
Use of gift		 (d)
Description of how gift is held
 
(e)
Transfer of gift
Transferee's name, address, and ZIP 4 Relationship of transferor to transferee
 
 
       
 
(a) No.
from
Part I		 (b)
Purpose of gift		 (c)
Use of gift		 (d)
Description of how gift is held
 
(e)
Transfer of gift
Transferee's name, address, and ZIP 4 Relationship of transferor to transferee
 
 
       
 
Schedule B (Form 990, 990-EZ, or 990-PF) (2010)

Additional Data


Software ID:  
Software Version:  
SCHEDULE D
(Form 990)
Department of the Treasury
Internal Revenue Service
Supplemental Financial Statements
SchDMd Bullet Complete if the organization answered "Yes," to Form 990,
Part IV, line 6, 7, 8, 9, 10, 11, or 12.
SchDMd Bullet Attach to Form 990. SchDMd Bullet See separate instructions.
OMB No. 1545-0047
2010
Open to Public Inspection
Name of the organization
The Michael J Fox Foundation
FOR PARKINSON'S RESEARCH
Employer identification number

13-4141945
Part I
Organizations Maintaining Donor Advised Funds or Other Similar Funds or Accounts. Complete if the organization answered "Yes" to Form 990, Part IV, line 6.
(a) Donor advised funds (b) Funds and other accounts
1 Total number at end of year .......    
2 Aggregate contributions to (during year) ...    
3 Aggregate grants from (during year) ...    
4 Aggregate value at end of year .......    
5
Did the organization inform all donors and donor advisors in writing that the assets held in donor advised
funds are the organization's property, subject to the organization's exclusive legal control? ............
6
Did the organization inform all grantees, donors, and donor advisors in writing that grant funds may be
used only for charitable purposes and not for the benefit of the donor or donor advisor, or for any other purpose conferring impermissible private benefit. ...................................
Part II
Conservation Easements. Complete if the organization answered "Yes" to Form 990, Part IV, line 7.
1
Purpose(s) of conservation easements held by the organization (check all that apply).
2
Complete lines 2a–2d if the organization held a qualified conservation contribution in the form of a conservation easement on the last day of the tax year.
Held at the End of the Year
a Total number of conservation easements ....................... 2a  
b Total acreage restricted by conservation easements .................. 2b  
c Number of conservation easements on a certified historic structure included in (a) ..... 2c  
d Number of conservation easements included in (c) acquired after 8/17/06 ........ 2d  
3
Number of conservation easements modified, transferred, released, extinguished, or terminated by the organization during
the taxable year SchDMd Bullet  
4
Number of states where property subject to conservation easement is located SchDMd Bullet  
5
Does the organization have a written policy regarding the periodic monitoring, inspection, handling of violations, and
enforcement of the conservation easements it holds? .............................
6
Staff and volunteer hours devoted to monitoring, inspecting and enforcing conservation easements during the year SchDMd Bullet  
7
Amount of expenses incurred in monitoring, inspecting, and enforcing conservation easements during the year SchDMd Bullet $  
8
Does each conservation easement reported on line 2(d) above satisfy the requirements of section
170(h)(4)(B)(i) and 170(h)(4)(B)(ii)? ....................................
9
In Part XIV, describe how the organization reports conservation easements in its revenue and expense statement, and
balance sheet, and include, if applicable, the text of the footnote to the organization’s financial statements that describes
the organization’s accounting for conservation easements.
Part III
Organizations Maintaining Collections of Art, Historical Treasures, or Other Similar Assets.
Complete if the organization answered "Yes" to Form 990, Part IV, line 8.
1a
If the organization elected, as permitted under SFAS 116, not to report in its revenue statement and balance sheet works of
art, historical treasures, or other similar assets held for public exhibition, education or research in furtherance of public service,
provide, in Part XIV, the text of the footnote to its financial statements that describes these items.
b
If the organization elected, as permitted under SFAS 116, to report in its revenue statement and balance sheet works of art,
historical treasures, or other similar assets held for public exhibition, education, or research in furtherance of public service,
provide the following amounts relating to these items:
(i)
Revenues included in Form 990, Part VIII, line 1 ........................SchDMd Bullet $  
(ii)
Assets included in Form 990, Part X ..............................SchDMd Bullet $  
2
If the organization received or held works of art, historical treasures, or other similar assets for financial gain, provide the
following amounts required to be reported under SFAS 116 relating to these items:
a
Revenues included in Form 990, Part VIII, line 1 ..........................SchDMd Bullet $  
b
Assets included in Form 990, Part X ...............................SchDMd Bullet $  
For Privacy Act and Paperwork Reduction Act Notice, see the Intructions for Form 990
Cat. No. 52283D
Schedule D (Form 990) 2010

Schedule D (Form 990) 2010
Page 2
Part III
Organizations Maintaining Collections of Art, Historical Treasures, or Other Similar Assets (continued)
3
Using the organization’s accession and other records, check any of the following that are a significant use of its collection
items (check all that apply):
a
d
b
e
 
c
4
Provide a description of the organization’s collections and explain how they further the organization’s exempt purpose in
Part XIV.
5
During the year, did the organization solicit or receive donations of art, historical treasures or other similar
assets to be sold to raise funds rather than to be maintained as part of the organization’s collection?........
Part IV
Escrow and Custodial Arrangements. Complete if the organization answered "Yes" to Form 990,
Part IV, line 9, or reported an amount on Form 990, Part X, line 21.
1a
Is the organization an agent, trustee, custodian or other intermediary for contributions or other assets not
included on Form 990, Part X? ....................................
b
If "Yes," explain the arrangement in Part XIV and complete the following table:
Amount
c Beginning balance ................................. 1c  
d Additions during the year .............................. 1d  
e Distributions during the year ............................. 1e  
f Ending balance ................................... 1f  
2a
Did the organization include an amount on Form 990, Part X, line 21? .....................
b
If “Yes,” explain the arrangement in Part XIV.
Part V
Endowment Funds. Complete if the organization answered "Yes" to Form 990, Part IV, line 10.
(a)Current Year (b)Prior Year (c)Two Years Back (d)Three Years Back (e)Four Years Back
1a Beginning of year balance ....      
b Contributions ........      
c Investment earnings or losses ...      
d Grants or scholarships .....      
e Other expenditures for facilities
and programs ........ 		     
f Administrative expenses ....      
g End of year balance ......      
2
Provide the estimated percentage of the year end balance held as:
a
Board designated or quasi-endowment: SchDMd Bullet  
b
Permanent endowment: SchDMd Bullet  
c
Term endowment: SchDMd Bullet  
3a
Are there endowment funds not in the possession of the organization that are held and administered for the
organization by:

Yes
No
(i) unrelated organizations ........................
3a(i)
 
 
(ii) related organizations ........................
3a(ii)
 
 
b
If "Yes" to 3a(ii), are the related organizations listed as required on Schedule R? .........
3b
 
 
4
Describe in Part XIV the intended uses of the organization's endowment funds.
Part VI
Investments—Land, Buildings, and Equipment. See Form 990, Part X, line 10.
Description of investment (a) Cost or other basis (investment) (b)Cost or other basis (other) (c) Accumulated depreciation (d) Book value
1a Land .................      
b Buildings ................        
c Leasehold improvements ............   304,571 155,482 149,089
d Equipment ................   683,445 0 103,619
e Other .................   232,983 0 84,352
Total. Add lines 1a-1e. (Column (d) should equal Form 990, Part X, column (B), line 10(c).)........SchDMdBullet 337,060
Schedule D (Form 990) 2010

Schedule D (Form 990) 2010
Page 3
Part VII
Investments—Other Securities. See Form 990, Part X, line 12.
(a) Description of security or category
(including name of security)		 (b)Book value (c) Method of valuation:
Cost or end-of-year market value
(1)Financial derivatives    
(2)Closely-held equity interests    
Other








Total. (Column (b) should equal Form 990, Part X, col.(B) line 12.)Small Bullet  
Part VIII
Investments—Program Related. See Form 990, Part X, line 13.
(a) Description of investment type (b) Book value (c) Method of valuation:
Cost or end-of-year market value








Total. (Column (b) should equal Form 990, Part X, col.(B) line 13.)Small Bullet  
Part IX
Other Assets. See Form 990, Part X, line 15.
(a) Description (b) Book value








Total. (Column (b) should equal Form 990, Part X, col.(B) line 15.)...........Small Bullet  
Part X
Other Liabilities. See Form 990, Part X, line 25.
1.(a) Description of Liability (b) Amount
Federal Income Taxes 0
DEFERRED RENT 349,036
DUE TO MJFF CANADA 169,493
INTEREST PAYABLE 108,059






Total. (Column (b) should equal Form 990, Part X, col.(B) line 25.)Small Bullet 626,588
2. Fin 48 (ASC 740) Footnote. In Part XIV, provide the text of the footnote to the organization's financial statements that reports the organization's liability for uncertain tax positions under FIN 48 (ASC740).
Schedule D (Form 990) 2010

Schedule D (Form 990) 2010
Page 4
Part XI Reconciliation of Change in Net Assets from Form 990 to Financial Statements
1 Total revenue (Form 990, Part VIII, column (A), line 12) .................... 1 57,621,460
2 Total expenses (Form 990, Part IX, column (A), line 25) ..................... 2 60,056,544
3 Excess or (deficit) for the year. Subtract line 2 from line 1 ............. 3 -2,435,084
4 Net unrealized gains (losses) on investments .......................... 4 -4,743
5 Donated services and use of facilities ............................. 5  
6 Investment expenses ................................... 6  
7 Prior period adjustments .................................. 7  
8 Other (Describe in Part XIV) ................................. 8  
9 Total adjustments (net). Add lines 4 - 8 ............................. 9 -4,743
10 Excess or (deficit) for the year per financial statements. Combine lines 3 and 9 ......... 10 -2,439,827
Part XII Reconciliation of Revenue per Audited Financial Statements With Revenue per Return
1 Total revenue, gains, and other support per audited financial statements ....... 1 57,630,995
2 Amounts included on line 1 but not on Form 990, Part VIII, line 12:
a Net unrealized gains on investments .......... 2a -4,743
b Donated services and use of facilities ......... 2b  
c Recoveries of prior year grants ........... 2c  
d Other (Describe in Part XIV): ............ 2d 14,278
e Add lines 2a through 2d ..................... 2e 9,535
3 Subtract line 2e from line 1..................... 3 57,621,460
4 Amounts included on Form 990, Part VIII, line 12, but not on line 1:
a Investment expenses not included on Form 990, Part VIII, line 7b . 4a  
b Other (Describe in Part XIV): ........... 4b  
c Add lines 4a and 4b....................... 4c  
5 Total Revenue. Add lines 3 and 4c. (This should equal Form 990, Part I, line 12.) ...... 5 57,621,460
Part XIII Reconciliation of Expenses per Audited Financial Statements With Expenses per Return
1 Total expenses and losses per audited financial statements ............. 1 60,070,822
2 Amounts included on line 1 but not on Form 990, Part IX, line 25:
a Donated services and use of facilities .......... 2a  
b Prior year adjustments .............. 2b  
c Other losses ................ 2c  
d Other (Describe in Part XIV): ............ 2d 14,278
e Add lines 2a through 2d...................... 2e 14,278
3 Subtract line 2e from line 1..................... 3 60,056,544
4 Amounts included on Form 990, Part IX, line 25, but not on line 1:
a Investment expenses not included on Form 990, Part VIII, line 7b .. 4a  
b Other (Describe in Part XIV): ............ 4b  
c Add lines 4a and 4b....................... 4c  
5 Total expenses. Add lines 3 and 4c. (This should equal Form 990, Part I, line 18.) ...... 5 60,056,544
Part XIV
Supplemental Information
Complete this part to provide the descriptions required for Part II, lines 3, 5, and 9; Part III, lines 1a and 4; Part lV, lines 1b and 2b;
Part V, line 4; Part X; Part XI, line 8; Part XII, lines 2d and 4b; and Part XIII, lines 2d and 4b. Also complete this part to provide any additional information.
Identifier Return Reference Explanation
Scheduel D, Page 3, Question 2: ASC 740-10-05 Footnote Income taxes: The Foundation is subject to the provisions of the Financial Accounting Standards Board's Accounting Standards Codification ("ASC") 740-10-05 relating to accounting and reporting for uncertainty in income taxes. For the Foundation, ASC 740-10-05 is potentially applicable to the incurrence of unrelated business income ("UBIT") attributable to certain of the Foundation's merchandise sales. The adoption of ASC 740-10-05 has not had, and is not expected to have, a material impact on the Foundation's financial statements.
RECONCILIATION OF EXPENSES SCHEDULE D, PART XIII, LINE 2D, PAGE 4 EXPENSES ATTRIBUTABLE TO THE MICHAEL J. FOX FOUNDATION FOR PARKINSON'S RESEARCH'S CANADIAN ENTITY.
Schedule D (Form 990) 2010

Additional Data


Software ID:  
Software Version:  




SCHEDULE F
(Form 990)

Department of the Treasury
Internal Revenue Service
Statement of Activities Outside the United States
Right pointing arrow large image Complete if the organization answered "Yes" to Form 990,
Part IV, line 14b, 15, or 16.
Right pointing arrow large image Attach to Form 990. Right pointing arrow large image See separate instructions.
OMB No. 1545-0047
2010
Open to Public Inspection
Name of the organization
The Michael J Fox Foundation
FOR PARKINSON'S RESEARCH
Employer identification number

13-4141945
Part I
General Information on Activities Outside the United States. Complete if the organization answered
“Yes” to Form 990, Part IV, line 14b.
1
For grantmakers. Does the organization maintain records to substantiate the amount of the grants or
assistance, the grantees' eligibility for the grants or assistance, and the selection criteria used to award
the grants or assistance? ...................................
2
For grantmakers. Describe in Part V the organization’s procedures for monitoring the use of grant funds outside the
United States.
3
Activites per Region. (Use Part V if additional space is needed.)
(a) Region (b) Number of offices in the region (c) Number of employees or agents in region or independent contractors (d) Activities conducted in region (by type) (e.g., fundraising, program services, investments, grants to recipients located in the region) (e) If activity listed in (d) is a program service, describe specific type of
service(s) in region		 (f) Total
expenditures for region/investments
in region
East Asia and the Pacific 0 0 Grantmaking   1,303,250
Europe (Including Iceland and Greenland) 0 0 Grantmaking   9,803,216
Middle East and North Africa 0 0 Grantmaking   1,241,267
North America 0 0 Grantmaking   4,318,064
South America 0 0 Grantmaking   125,000
           
           
           
           
           
           
           
           
           
           
           
           
3a Sub-total ..... 0 0 16,790,797
b Total from continuation sheets to Part I ...      
c Totals (add lines 3a and 3b) 0 0 16,790,797
For Privacy Act and Paperwork Reduction Act Notice, see the Instructions for Form 990.Cat. No. 50082W Schedule F (Form 990) 2010
Schedule F (Form 990) 2010
Page 2
Part II
Grants and Other Assistance to Organizations or Entities Outside the United States. Complete if the organization answered "Yes" to Form 990,
Part IV, line 15, for any recipient who received more than $5,000. Check this box if no one recipient received more than $5,000 ........ MediumBullet
Use Part V if additional space is needed.
1 (a) Name of organization (b) IRS code section
and EIN (if applicable)		 (c) Region (d) Purpose of
grant 		(e) Amount of
cash grant 		(f) Manner of
cash
disbursement 		(g) Amount of
of non-cash
assistance 		(h) Description
of non-cash
assistance 		(i) Method of
valuation
(book, FMV,
appraisal, other)
Europe/Iceland/Greenland Phase II, randomized, double-blind, placebo-controlled, parallel group, multicentre study to evaluate the safety, tolerability and efficacy of ADX48621 in the treatment of moderate to severe L-dopa induced dyskinesia in patients with Parkinson's disease 900,000        
Europe/Iceland/Greenland AFFITOPE based immunotherapeutic strategies for Parkinson?s disease 475,000        
North America Testing of davunetide for intranasal administration in mice overexpressing alpha--synuclein 625,535        
Europe/Iceland/Greenland A Phase IIa, Multi-Centre, Double-Blind, Randomised, Placebo-Controlled, Parallel Group 12-Month Study to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of AZD3241 in Patients with Multiple System Atrophy 500,000        
East Asia/Pacific Genetic and Environmental Modifiers for LRRK2 Associated PD 624,250        
East Asia/Pacific Resting state fMRI as a Biomarker for Parkinson's Disease 75,000        
Europe/Iceland/Greenland Diversity Panel profiling of the LRRK2-IN1 compound 9,757        
North America Functional Genomic Screening to Identify Novel Regulators of Parkinson's 74,772        
East Asia/Pacific Optimization of the ELISA for oxidized DJ-1 125,000        
Europe/Iceland/Greenland Validation of enzymatic activity and neuropathology in G2019S LRRK2-induced dopaminergic neurodegeneration in a rat model of Parkinson's disease 308,425        
Europe/Iceland/Greenland Investigation of PDE10a Inhibitors for Parkinsons Disease. PI is Bart Ellenbroek. 196,515        
Europe/Iceland/Greenland In Vivo Assessment of Alpha-Synuclein Secretion 150,000        
Europe/Iceland/Greenland Lamp-2a as a therapeutic traget in Parkinson's Disease 125,000        
Europe/Iceland/Greenland Selective neuroprotective effects of the S18Y polymorphic variant of UCH-L1 37,500        
Europe/Iceland/Greenland Modulation of the Rho Kinase pathway for improvement of regeneration in PD 248,215        
Middle East/North Africa Susceptibility genes for antipsychotic-induced extrapyramidal symptoms as modifier genes in Parkinson's disease and L-dopa treatment response 74,998        
Europe/Iceland/Greenland ASAP study: ASymptomatic LRRK2 mutation carriers and Assessment of factors influencing LRRK2-related PD expression study 745,168        
Europe/Iceland/Greenland PPMI Clinical Site 257,031        
Europe/Iceland/Greenland NeuroEPIC Parkinson's disease study 150,000        
Europe/Iceland/Greenland Deciphering the molecular effects of alpha-synuclein in the nucleus: DNA binding and transcriptional dysregulation 74,800        
Europe/Iceland/Greenland mTORC1 as a target for the treatment of L-DOPA-induced dyskinesia 249,875        
Europe/Iceland/Greenland Validation of FKBP inhibitors to target alpha-synuclein pathology in rodent brain 202,656        
Europe/Iceland/Greenland The Sigma 1 receptor as a target for disease modifying therapies in Parkinson's disease 248,406        
Europe/Iceland/Greenland The role of mGluR4 in the modulation of L-DOPA-induced motor performance and dyskinesia in a rat model of Parkinson's disease 193,385        
Europe/Iceland/Greenland Proof-of-concept clinical trial on the use of the 5-HT1A/1B partial agonist Eltoprazine for treatment of L-DOPA-induced dyskinesias 101,396        
Europe/Iceland/Greenland Development of in vivo models of prion-like transfer of alpha-synuclein 95,867        
Europe/Iceland/Greenland Down-regulation of GDNF signaling in the a-synuclein model of PD: implications for the use of GDNF in neuroprotective therapy 75,000        
Europe/Iceland/Greenland Determine the structure of Roco family proteins 74,999        
North America Intermittent Bilateral Intraputamenal Treatment with GDNF 2,100,000        
Europe/Iceland/Greenland Flibanserin in Levodopa-induced Dyskinesia: MPTP-lesioned Pre-clinical Model 162,250        
East Asia/Pacific Nasal PD Treatment-Proof-of-Concept 75,000        
Middle East/North Africa Maintenance of continuous plasma levodopa levels through continuous subcutaneous carbidopa administration 1,000,000        
North America Delayed Start Assessment of Progranulin in a Progressive Rodent Model of Parkinson?s Disease 113,630        
Europe/Iceland/Greenland The Trondheim LRRK2 cohort program 199,875        
East Asia/Pacific MJFF-Elan Partnership - OzGene Mouse Generation 64,500        
Europe/Iceland/Greenland PPMI Clinical Trial Site 257,031        
Europe/Iceland/Greenland Laboratory phenotyping of Parkinson disease subjects using a multiplex approach 249,894        
Europe/Iceland/Greenland Ghrelin - a peripheral, preclinical biomarker for Parkinson's disease (PD) 216,250        
Middle East/North Africa Clinical Assessment of Patients with PD Who Underwent DAT Scan and FDG PET at the Early Stages of Their Extra-Pyramidal Disorder as Part of Their Initial Workup 91,670        
Middle East/North Africa Biofeedback-based motor learning to ameliorate freezing of gait 74,599        
Europe/Iceland/Greenland The role of LRRK2 in Wnt signaling in vivo 97,896        
Europe/Iceland/Greenland Is glucose metabolism perturbed in PD? 50,100        
Europe/Iceland/Greenland Biochemical characterization of full length human recombinant LRRK1 and LRRK2 - supplemental funding 200,000        
Europe/Iceland/Greenland Coordinated reset (CR) stimulation of the subthalamic nucleus in the MPTP non-human primate model: Target validation for translating into a clinical trial in PD patients 128,810        
Europe/Iceland/Greenland Langston Award 2010 25,000        
North America Increased dopamine turnover as a manifestation of LRRK2 mutation 395,105        
North America LRRK2 G2019S disease penetrance modifiers 262,066        
North America Multi-tracer positron emission tomography (PET) functional imaging as a tool to assess the relevance of rodent LRRK2 models to the human neurochemical phenotype associated with LRRK2 mutations related Parkinsonism 259,416        
North America The Role of LRRK2 in Neurotransmission 162,564        
South America Targeting the Unfolded Protein Response (UPR) transcription factor XBP-1 to treat Parkinson's disease. 125,000        
Europe/Iceland/Greenland Exploiting Ser910/935 phosphorylation and 14-3-3 binding to develop biomarkers for LRRK2 activity 193,750        
Europe/Iceland/Greenland CDNF (Cerebral Dopamine Neurotrophic Factor) for therapy of Parkinson's disease 515,086        
Europe/Iceland/Greenland PPMI Clinical Trial Site 257,031        
North America INCREASED DOPAMINE TRANSPORTER FUNCTION AS AN EARLY PHENOTYPE OF PD, PRIOR TO DOPAMINE NEURON CELL DEATH 74,976        
North America Functional Analysis of LRRK2: Focus on autophagy 250,000        
Europe/Iceland/Greenland CSF LYSOSOMAL HYDROLASES' ACTIVITY AS POSSIBLE MARKER OF PARKINSON'S DISEASE 75,000        
Europe/Iceland/Greenland Prospective validation of risk markers for the development of Parkinson's disease 491,132        
Europe/Iceland/Greenland Macrophage Precursors as Biomarker for LRRK2-associated Parkinson disease 395,000        
Europe/Iceland/Greenland Longitudinal Follow up of clinical and neuroimaging signs as well as biomarkers in symptomatic and asymptomatic LRRK2 mtuation carriers in comparison to indiopathic PD and controls 382,500        
Europe/Iceland/Greenland PPMI Clinical Trial Site 257,031        
Europe/Iceland/Greenland Immuno-PCR detection of alpha-synuclein phosphorylated at serine-129 as PD biomarker 155,785        
Europe/Iceland/Greenland Genetic-epidemiological confirmation of top hits of GWAS of Parkinson disease: A large multi-center collaborative study. 74,800        
2
Enter total number of recipient organizations listed above that are recognized as charities by the foreign country, recognized as tax-exempt by the IRS, or for which the grantee or counsel has provided a section 501(c)(3) equivalency letter .....MediumBullet
50
3
Enter total number of other organizations or entities ........................MediumBullet
12
Schedule F (Form 990) 2010
Schedule F (Form 990) 2010Page 3
Part III
Grants and Other Assistance to Individuals Outside the United States. Complete if the organization answered "Yes" to Form 990, Part IV, line 16.
Use Part V if additional space is needed.
(a) Type of grant or assistance (b) Region (c) Number of recipients (d) Amount of
cash grant 		(e) Manner of cash
disbursement 		(f) Amount of
non-cash
assistance 		(g) Description
of non-cash
assistance 		(h) Method of
valuation
(book, FMV,
appraisal, other)
               
               
               
               
               
               
               
               
               
               
               
               
               
               
               
               
               
               
Schedule F (Form 990) 2010
Schedule F (Form 990) 2010
Page 4
Part IV
Foreign Forms
1 Was the organization a U.S. transferor of property to a foreign corporation during the tax year? If "Yes," the organization may be required to file Form 926 (see instructions for Form 926).................
2 Did the organization have an interest in a foreign trust during the tax year? If " Yes," the organization may be required to file Form 3520 and/or Form 3520-A. (see instructions for Forms 3520 and 3520-A)..........
3 Did the organization have an ownership interest in a foreign corporation during the tax year? If "Yes," the organization may be required to file Form 5471, Information Return of U.S. Persons with respect to Certain Foreign Corporations. (see instructions for Form 5471)..............................
4 Was the organization a direct or indirect shareholder of a passive foreign investment company or a qualified electing fund during the tax year? If "Yes," the organization may be required to file Form 8621, Return by a Shareholder of a Passive Foreign Investment Company or Qualified Electing Fund. (see instructions for Form 8621)
5 Did the organization have an ownership interest in a foreign partnership during the tax year? If "Yes," the organization may be required to file Form 8865, Return of U.S. Persons with respect to Certain Foreign Partnerships. (see instructions for Form 8865)....................................
6 Did the organization have any operations in or related to any boycotting countries during the tax year? If "Yes," the organization may be required to file Form 5713, International Boycott Report (see instructions for Form 5713)................................................
Schedule F (Form 990) 2010
Schedule F (Form 990) 2010
Page 5
Part V
Supplemental Information
Complete this part to provide the information (see instructions) required in Part I, line 2, and any additional information.
Identifier ReturnReference Explanation
SCHEDULE F PROCEDURES FOR MONITORING GRANT FUNDS OUTSIDE THE UNITED STATES: THE FOUNDATION AWARDS RESEARCH GRANTS BASED UPON THE GUIDANCE AND INPUT OF THE SCIENTIFIC ADVISORY BOARD AND OTHER HIGHLY REGARDED SCIENTISTS WHO SERVE ON GRANT REVIEW COMMITTEES SPECIALIZING IN PARKINSON'S RESEARCH. Goals and milestones are described within each grant award. Most Grant awards are allocated in multiple payments with key benchmarks set at the time of the grant award. MJFF's Research team closely monitors the progress of each grant awarded. There is frequent communication between grantees and MJFF staff regarding the progress of each grant. Progress is verified before additional payments are made.
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
Schedule F (Form 990) 2010
Additional Data


Software ID:  
Software Version:  



SCHEDULE G
(Form 990 or 990-EZ)
Department of the Treasury
Internal Revenue Service
Supplemental Information Regarding
Fundraising or Gaming Activities
Complete if the organization answered "Yes" to Form 990, Part IV, lines 17, 18, or 19,
or if the organization entered more than $15,000 on Form 990-EZ, line 6a.
right arrow Attach to Form 990 or Form 990-EZ. right arrow See separate instructions.
OMB No. 1545-0047
2010
Open to Public Inspection
Name of the organization
The Michael J Fox Foundation
FOR PARKINSON'S RESEARCH
Employer identification number

13-4141945
Part I
Fundraising Activities. Complete if the organization answered "Yes" to Form 990, Part IV, line 17.
1
Indicate whether the organization raised funds through any of the following activities. Check all that apply.
a e
b f
c g
d
2a
Did the organization have a written or oral agreement with any individual (including officers, directors, trustees
or key employees listed in Form 990, Part VII) or entity in connection with professional fundraising services?
b
If “Yes,” list the ten highest paid individuals or entities (fundraisers) pursuant to agreements under which the fundraiser is
to be compensated at least $5,000 by the organization. Form 990-EZ filers are not required to complete this table.
(i) Name and address of individual
or entity (fundraiser) 		(ii) Activity (iii) Did fundraiser have custody or control of contributions? (iv) Gross receipts
from activity 		(v) Amount paid to
(or retained by)
fundraiser listed in
col. (i) 		(vi) Amount paid to
(or retained by)
organization
Yes No
Event Associates Inc
162 WEST 56TH STREET 405
 
NEW YORK, NY10019 		Fundraising Consultants   No 0 49,600 0
Total .................right arrow 0 49,600 0
3
List all states in which the organization is registered or licensed to solicit funds or has been notified it is exempt from registration or licensing.
AL, AK, AZ, AR, CA, CO, CT, FL, GA, IL, KS, KY, ME, MD, MA, MI, MN, MS, NH, NJ, NM, NY, NC, ND, OH, OK, OR, PA, RI, SC, TN, UT, VA, WA, WV, WI
For Privacy Act and Paperwork Reduction Act Notice, see the Instructions for Form 990.
Cat. No. 50083H
Schedule G (Form 990 or 990-EZ) 2010
Schedule G (Form 990 or 990-EZ) 2010
Page 2
Part II
Fundraising Events. Complete if the organization answered "Yes" to Form 990, Part IV, line 18, or reported more than $15,000 on Form 990-EZ, line 6a. List events with gross receipts greater than $5,000.
(a) Event #1

FUNNY THING
(event type) 		(b) Event #2

SUNNY THING
(event type) 		(c) Other Events

3
(total number) 		(d) Total Events
(Add col. (a) through col. (c))
VerticalRevenue 1 Gross receipts . . . 4,692,806 875,650 1,778,361 7,346,817
2 Less: Charitable
contributions . . . 		4,481,056 823,400 1,683,821 6,988,277
3 Gross income (line 1
minus line 2) . . . 		211,750 52,250 94,540 358,540
VerticalDirectExpenses 4 Cash prizes . . .        
5 Non-cash prizes . .        
6 Rent/facility costs . .        
7 Food and beverages . .        
8 Entertainment . . .        
9 Other direct expenses . 211,750 52,250 94,540 358,540
10 Direct expense summary. Add lines 4 through 9 in column (d) ........... right arrow 358,540
11 Net income summary. Combine lines 3 and 10 in column (d)............ right arrow  
Part III
Gaming. Complete if the organization answered "Yes" to Form 990, Part IV, line 19, or reported more than $15,000 on Form 990-EZ, line 6a.
VerticalRevenue (a) Bingo (b) Pull tabs/Instant
bingo/progressive bingo 		(c) Other gaming (d) Total gaming (Add col. (a) through col. (c))
1 Gross revenue . . . .        
VerticalDirectExpenses 2 Cash prizes . . . .        
3 Non-cash prizes . . .        
4 Rent/facility costs . . .        
5 Other direct expenses . .        
6 Volunteer labor . . .
 
 
 
7 Direct expense summary. Add lines 2 through 5 in column (d) ........... right arrow  
8 Net gaming income summary. Combine lines 1 and 7 in column (d) .......... right arrow  
9
Enter the state(s) in which the organization operates gaming activities:
a
Is the organization licensed to operate gaming activities in each of these states? ............
b
If "No," Explain:
 
10a
Were any of the organization's gaming licenses revoked, suspended or terminated during the tax year? .....
b
If "Yes," Explain:
 
11
Does the organization operate gaming activities with nonmembers? .................
12
Is the organization a grantor, beneficiary or trustee of a trust or a member of a partnership or other entity
formed to administer charitable gaming? ...........................
Schedule G (Form 990 or 990-EZ) 2010
Schedule G (Form 990 or 990-EZ) 2010
Page 3
13
Indicate the percentage of gaming activity operated in:
a
The organization's facility ......................
13a
 
b
An outside facility ........................
13b
 
14
Provide the name and address of the person who prepares the organization's gaming/special events books and records:
Name right arrow
Address right arrow
15a
Does the organization have a contract with a third party from whom the organization receives gaming
revenue? ......................................
b
If "Yes," enter the amount of gaming revenue received by the organization right arrow $   and the
amount of gaming revenue retained by the third party right arrow $   .
c
If "Yes," enter name and address:
Name right arrow
Address right arrow
 
 
16
Gaming manager information:
Name right arrow
Gaming manager compensation right arrow $  
Description of services provided right arrow
 
17
Mandatory distributions:
a
Is the organization required under state law to make charitable distributions from the gaming proceeds to
retain the state gaming license? ............................
b
Enter the amount of distributions required under state law distributed to other exempt organizations or spent
in the organization's own exempt activities during the tax year right arrow$  
Part IV
Complete this part to provide additional information for responses to quuestion on Schedule G (see instructions.)
Identifier ReturnReference Explanation
Schedule G (Form 990 or 990-EZ) 2010
Additional Data


Software ID:  
Software Version:  
Schedule I
(Form 990)
Department of the Treasury
Internal Revenue Service
Grants and Other Assistance to Organizations,
Governments and Individuals in the United States
Complete if the organization answered "Yes," to Form 990, Part IV, line 21 or 22.
lBullet Attach to Form 990
OMB No. 1545-0047
2010
Open to Public
Inspection
Name of the organization
The Michael J Fox Foundation
FOR PARKINSON'S RESEARCH
Employer identification number
13-4141945
Part I
General Information on Grants and Assistance
1
Does the organization maintain records to substantiate the amount of the grants or assistance, the grantees' eligibility for the grants or assistance, and
the selection criteria used to award the grants or assistance? ....................................
2
Describe in Part IV the organization's procedures for monitoring the use of grant funds in the United States.
Part II
Grants and Other Assistance to Governments and Organizations in the United States. Complete if the organization answered "Yes" to
Form 990, Part IV, line 21 for any recipient that received more than $5,000. Check this box if no one recipient received more than $5,000. Use
Part IV and Schedule I-1 (Form 990) if additional space is needed ......................... lBullet
(a) Name and address of organization
or government		 (b) EIN (c) IRC Code section
if applicable		 (d) Amount of cash grant (e) Amount of non-cash
assistance		 (f) Method of valuation
(book, FMV, appraisal,
other)		 (g) Description of
non-cash assistance		 (h) Purpose of grant
or assistance
(1) Acadia Pharmaceuticals3911 Sorrento Valley Blvd
San Diego,CA92121 		06-1376651   301,015       Development of Nurr1-RXR heterodimer selective ago agonists for Parkinson's disease
(2) Adolor Corporation700 Pennsylvania Drive
Exton,PA19341 		31-1429198   363,400       Optimization of MOR Antagonists for the Treatment of L-DOPA-Induced Dyskinesias in Parkinson's Disease
(3) Amarantus Therapeutics Inc675 Almanor Avenue
Sunnyvale,CA94085 		26-1758388   370,717       Comparison and Actions of MANF and GDNF in Rodent Models of Parkinson's Disease
(4) Amicus Therapeutics6 Cedar Brook Drive
Cranbury,NJ08512 		71-0869350   499,503       Use of the orally administered pharmacological cha chaperone AT3375 to reduce alpha-synuclein levels in the brain of Thy-1 alpha-synuclein mice
(5) Arizona State University1711 S Rural Road Box 6006
Tempe,AZ85287 		01-9669600 501(C)(3) 552,273       Morphology specific anti-synuclein nanobodies as t therapeutics for PD
(6) Arizona State University1711 S Rural Road Box 6006
Tempe,AZ85287 		01-9669600 501(C)(3) 156,251       Identifying and localizing toxic oligomeric a-syn with morphology specific nanobodies
(7) Arizona State University1711 S Rural Road Box 6006
Tempe,AZ85287 		01-9669600 501(C)(3) 110,000       In vivo SPECT Imaging of synuclein aggregation wit with morphology specific antibody based ligands
(8) Athersys Inc3201 Carnegie Avenue
Cleveland,OH44115 		34-1830213   140,590       Development of an Adult Adherent Allogeneic Stem C Cell Product for Treatment of Parkinson's Disease
(9) Avid Radiopharmaceuticals Inc3711 Market Street
Philadelphia,PA19104 		20-1811104   493,438       18F-labeled alpha-synuclein ligands for PET imagin imaging of Lewy bodies
(10) Baylor College of MedicineThe Smith Tower
Houston,TX77030 		74-1613878 501(C)(3) 257,031       PPMI Clinical Trial Site
(11) Beth Israel Deaconess Medical Center330 Brookline Ave
Boston,MA02445 		04-2103881 501(C)(3) 100,000       PGC-1 Alpha as a Neuroprotective Target in Parkins Parkinson's Disease
(12) Beth Israel Medical Center10 Union Square East
New York,NY10003 		13-5564934 501(C)(3) 14,270       Parkinson's Disease, Ashkenazi Jews and LRRK2: a c consortium proposal - SUPPLEMENT
(13) Biomer Technology1047 Serpentine Lane Bldg 200
San Diego,CA94566 		  6,865       Generation of LRRK2 phospho-peptides
(14) Board of Regents of the University of Wisconsin Sy1415 Engineering Drive
Madison,WI53706 		39-6006492 501(C)(3) 187,476       Novel Antibodies for the Delivery of Parkinson's T Therapeutics
(15) Board of Regents of the University of Wisconsin Sy1111 Highland Avenue
Madison,WI53705 		39-6006492 501(C)(3) 90,157       Mechanism and Modulation of Alpha-Synuclein Expres Expression
(16) Boston University715 Albany St
Boston,MA02118 		04-2103545 501(C)(3) 257,031       PPMI Clinical Trial Site
(17) CalAsia Pharmaceuticals Inc11494 Sorrento Valley Road
San Diego,CA92121 		27-0641400   549,882       Novel, selective and potent brain-penetrant small molecule inhibitors of cytosolic Hsp90
(18) Case Western Reserve University2103 Cornell Road
Cleveland,OH44106 		34-1018992 501(C)(3) 221,634       Supplement-Characterization of LRRK2 cellular and signaling pathways
(19) Ceregene Inc9381 Judicial Drive Suite 130
San Diego,CA92121 		95-4838818   2,500,000       A Sham- Surgery Controlled Phase 2 Trial Testing A AAV2-neurturin (CERE-120) in Moderately Advanced Parkinson Disease
(20) Coriell Institute for Medical Research403 Haddon Avenue
Camden,NJ08103 		21-0672684 501(C)(3) 730,709       PPMI 2010: BioRepository
(21) Cortex Pharmaceuticals Inc15231 Barranca Parkway
Irvine,CA92618 		33-0303583   384,849       Assessment of the Neurorestorative Potential of En Enhanced Neurotrophic Support via Positive Glutamatergic Modulation in the MPTP Mouse Model of PD
(22) Cortex Pharmaceuticals Inc15231 Barranca Parkway
Irvine,CA92618 		33-0303583   7,177       Assessment of the Neurorestorative Potential of En Enhanced Neurotrophic Support via Positive Glutamatergic Modulation in the MPTP Mouse Model of PD-Supplement
(23) Covance8211 SciCor Drive
Indianapolis,IN46214 		22-3265977   388,784       PPMI Clinical Laboratory Analysis, PPMI study 001 001
(24) Covance180 Rustcraft Road
Indianapolis,IN02026 		22-3265977   155,000       Covance LRRK2 ELISA - Using Invitrogen LRRK2 Fragm Fragment, 5 MJFF Epitomics Antibodies, and 1 Neuromab Antibody
(25) Covance180 Rustcraft Road
Dedham,MA02026 		22-3265977   59,580       DJ-1 analysis in qualification study
(26) Covance180 Rustcraft Road
Indianapolis,IN02026 		22-3265977   25,000       DJ-1 Reproducibility & Year 1 Analyses in PPMI.
(27) Covance180 Rustcraft Road
Indianapolis,IN02026 		22-3265977   16,280       Hemoglobin Analysis in Qualification Study
(28) Covance180 Rustcraft Road
Dedham,MA02026 		22-3265977   9,000       Purification of novel alpha-synuclein polyclonal a antibodies
(29) Covance180 Rustcraft Road
Burlingame,CA02026 		22-3265977   6,000       Assay optimization to determine suitability of rab rabbit monoclonal antibodies
(30) Covance5858 Horton St Suite 500
Emeryville,CA94608 		22-3265977   5,777       Qualification Study - Covance handling of specimen specimens and running ELISA-PPMI prep
(31) Covance180 Rustcraft Road
Indianapolis,IN02026 		22-3265977   5,640       Covance Protein BCA Analysis
(32) Depomed Inc1360 OBrien Dr
Menlo Park,CA94025 		94-3329046   150,000       Study to Compare Levodopa/Carbidopa Safety, Tolera Tolerability, Pharmacokinetics and Pharmacodynamics following Administration of Gastric Retentive Extended-Release Tablets versus a Reference Extended-Release Tablet in Parkinson's Disease Patients
(33) Edmond and Lily Safra International Institute of NProf Francisco Luciano de Oliveira
Durham,NC59066 		501(C)(3) 236,498       Validation of Dorsal Column Electrical Stimulation Stimulation as a Target for Parkinson's Disease Therapy in 6-OHDA Non-human Primates
(34) Emerald BioStructures7869 NE Day Road West
Bainbridge Island,WA98110 		91-1821586   909,863       Determine the structure of LRRK2 protein
(35) Emerald BioStructures7869 NE Day Road West
Bainbridge Island,WA98110 		91-1821586   25,000       PINK1 Protein Generation
(36) Emory University1841 Clifton Road Third Floor
Atlanta,GA30329 		58-0566256 501(C)(3) 257,031       PPMI Clinical Trial Site
(37) Epitomics863 Mitten Road Suite 103
Burlingame,CA94010 		  166,678       LRRK2 Phospho-specific Polyclonal Antibody Generat Generation
(38) Epitomics863 Mitten Road
Burlingame,CA94010 		  64,352       LRRK2 rabbit monoclona antibody supplement - scale scale up
(39) Epitomics863 Mitten Road Suite 103
Burlingame,CA94010 		  30,872       PINK1 monoclonal rabbit antibody generation Form Formerly: Zou and Chen
(40) Epitomics863 Mitten Road Suite 103
Burlingame,CA94010 		  11,325       LRRK2 rabbit monoclonal antibody supplement - addi additional aliquotting and shipping of the LRRK2 antibodies- Formerly: Zou and Chen
(41) Gardedam Therapeutics651 Forest Avenue
Palo Alto,CA94301 		27-3699049   75,000       Identification of small-molecule stabilizers of DJ DJ-1: biophysical and cellular validation
(42) Georgetown University3970 Reservoir Road
Washington,DC20057 		53-0196603 501(C)(3) 74,249       SNCA haplotyping in Parkinson's disease and multip multiple system atrophy
(43) Harbor Biosciences4435 Eastgate Mall
San Diego,CA92121 		13-3697002   146,279       HE3286 as treatment for Parkinson's disease
(44) Harvard University250 Longwood Ave
Boston,MA02115 		42-1035800 501(C)(3) 575,185       Development of selective LRRK2 inhibitors
(45) Harvard University115 Mill Street
Belmont,MA02478 		42-1035800 501(C)(3) 294,899       Patient-specific iPS cell-derived neurons and dise disease-associated LRRK2 mutations for Parkinson's disease research
(46) Harvard University77 Avenue Louis Pasteur
Boston,MA02115 		42-1035800 501(C)(3) 200,000       Physiological and Pathological Implications of the the Unique Subcellular Distribution of LRRK2
(47) Harvard University240 Longwood Ave
Boston,MA02115 		42-1035800 501(C)(3) 124,898       Does the Ubiquitin Ligase, Nedd4, Protect Against Alpha-Synucleinopathy?
(48) Health Advances LLC9 Riverside Road
Watertown,MA02493 		11-1111111   15,000       Industry Landscape Update
(49) Indiana University410 West Tenth Street
Indianapolis,IN46202 		35-6001673 501(C)(3) 499,819       PROGENI Family Study
(50) Invitrogen Corporation501 Charmany Drive
Sunnyvale,CA53719 		33-0373077   72,400       LRRK2 Biochemical Studies (Invitrogen/Nichols Coll Collaboration)"
(51) Johns Hopkins University600 North Wolfe St
Baltimore,MD21287 		52-0595110 501(C)(3) 257,031       PPMI Clinical Trial Site
(52) Johns Hopkins UniversitySchool of Medicine
Baltimore,MD21205 		52-0595110 501(C)(3) 75,000       Identification and Validation of the modifiers of LRRK2-induced toxicity
(53) Massachusetts General Hospital114 16th St
Charlestown,MA02129 		04-2697983 501(C)(3) 249,043       Development and screening of contrast agents for i in vivo imaging of Parkinson's Disease
(54) Massachusetts General Hospital114 16th Street
Charlestown,MA02129 		04-2697983 501(C)(3) 127,324       Generation and characterization of iPS neurons fro from PINK1- and Parkin-linked Parkinson's disease
(55) Massachusetts General Hospital114 Sixteenth Street
Charlestown,MA02129 		04-2697983 501(C)(3) 77,329       Oligomeric equilibrium in male and female brains w with alpha-synuclein pathology
(56) Mayo Clinic4500 San Pablo Road South
Jacksonville,FL32224 		59-3337028 501(C)(3) 229,128       Global estimates for the role of LRRK2 variation i in Parkinsons disease susceptibility
(57) Mayo Clinic13400 E Shea Blvd
Jacksonville,FL85259 		59-3337028 501(C)(3) 25,000       Compensation to Dr Adler re Novel Hypotheses in P PD program
(58) McLean Hospital115 Mill Street
Belmont,MA02478 		04-2697981 501(C)(3) 255,173       Neuroprotective efficacy of RAB3B in animal models models of alpha-synucleinopathy
(59) McLean Hospital115 Mill Street
Belmont,MA02478 		04-2697981 501(C)(3) 132,603       Gait disturbances in Parkinson's disease: new link links to alpha-synuclein pathology
(60) Mount Sinai School of MedicineOne Gustave L Levy Place
New York,NY10029 		13-6171197 501(C)(3) 400,000       Determining pharmacodynamic biomarkers of LRRK2 ac activity in lymphocytes
(61) Mount Sinai School of MedicineOne Gustave L Levy Place
New York,NY10029 		13-6171197 501(C)(3) 262,818       LRRK2 Effects on Neural Differentiation
(62) National Institute on Aging35 Convent Drive
Bethesda,MD20892 		52-2038294 501(C)(3) 34,375       Biochemical characterization of full length human recombinant LRRK1 and LRRK2
(63) National Institute on Drug Abuse (NIDA)NIH251 Bayview Blvd
Baltimore,MD21224 		501(C)(3) 75,000       Dopamine D1-D3 receptor heteromer as a new target for Parkinson's disease
(64) Neuraltus Pharmaceuticals Inc2483 E Bayshore Rd Suite 212
Palo Alto,CA94303 		20-1008507   167,361       Targeting alpha-synuclein-lipid interactions in pr preclinical Parkinson's disease models.
(65) Neuroscience Associates10915 Lake Ridge Drive
Knoxville,TN37934 		62-1540123   349,188       Lrrk2 mouse characterization (histology)
(66) Neuroscience Associates10915 Lake Ridge Drive
Knoxville,TN37934 		62-1540123   245,566       KO rat characterization (histology)
(67) Neuroscience Associates10915 Lake Ridge Drive
Knoxville,TN37934 		62-1540123   122,783       KO rat characterization (histology)-LRRK2
(68) Northeastern University360 Huntington Avenue
Boston,MA02115 		04-1679980 501(C)(3) 375,000       Intranasal GDNF for Parkinson's Disease: Next Ste Steps in Preclinical Development
(69) Northern California Institute for Research & Educa4150 Clement St 114M
San Francisco,CA94121 		94-3084159 501(C)(3) 110,689       PPMI - 2010 - DTI Core
(70) Northwestern University710 North Lake Shore Drive
Chicago,IL60611 		36-2167817 501(C)(3) 257,031       PPMI Clinical Trial Site
(71) Northwestern University303 E Superior St
Chicago,IL60611 		36-2167817 501(C)(3) 74,762       Genetic dissection of Parkinson's disease vulnerab vulnerable dopaminergic neurons population
(72) Northwestern University710 North Lake Shore Drive
Chicago,IL60611 		36-2167817 501(C)(3) 58,885       A Pilot Phase II Double-Blind, Placebo-Controlled, Placebo-Controlled, Dosage Finding and Tolerability Study of Isradipine as a Disease Modifying Agent in Patients With Early Parkinson's Disease
(73) Omeros Corporation1420 Fifth Avenue
Seattle,WA98101 		91-1663741   76,442       Selective inhibition of cyclic nucleotide phosphod phosphodiesterase type 7 (PDE7): A novel and efficacious approach to treating Parkinson's disease
(74) Oregon Health & Science University3181 SW Sam Jackson Park Rd
Portland,OR97239 		93-1176109 501(C)(3) 257,031       PPMI Clinical Trial Site
(75) ParexelGlendale Adventist Medical Center
Glendale,CA91206 		04-3517643   55,156       Parexel Qualification Study
(76) PARK IP Translations134 W 29th Street
New York,NY10001 		20-8132576   15,000       PPMI Pre-Enrollment: Translation Services
(77) Parkinson's Action Network1025 Vermont Ave NW Suite 1120
Washington,DC20005 		94-3172675 501(C)(3) 250,000       PAN Funding 2010
(78) Pfizer Global Research and DevelopmentEastern Point Road
Princeton,NJ06340 		14-1396954   300,000       Elucidating the Function and Downstream Targets of of LRKK2
(79) PsychoGenics765 Old Saw Mill River Road
Tarrytown,NY10591 		  150,000       Support for your collaboration on 'Proof-of-concep 'Proof-of-concept clinical trial on the use of the 5-HT1A/1B partial agonist Eltoprazine for treatment of L-DOPA-induced dyskinesias. - Linked to Bjorklund CIA 2009
(80) Rush University1735 W Harrison Str
Chicago,IL60612 		36-2174823 501(C)(3) 230,025       A rodent model of pathological gambling associated associated with medicated parkinsonian patients.
(81) Rush University1735 West Harrison Street Suite 30
Chicago,IL60612 		36-2174823 501(C)(3) 219,185       A monkey alphasynuclein model of Parkinson's disea disease
(82) Rush University1735 West Harrison Street Suite 30
Chicago,IL60612 		36-2174823 501(C)(3) 74,999       Protecting innervation: Nmnat1 gene therapy for Pa Parkinson's disease
(83) Saint Jude Children's Research Hospital332 North Lauderdale
Memphis,TN38105 		16-2064601 501(C)(3) 88,096       Role of H1N1 influenza virus in the etiology of Pa Parkinson's disease.
(84) Saint Jude Children's Research Hospital332 North Lauderdale
Memphis,TN38105 		16-2064601 501(C)(3) 75,000       Development of a progressive familial mouse model of Parkinson's disease.
(85) Sangamo BioSciences Inc501 Canal Blvd Suite A100
Richmond,CA94804 		68-0359556   895,257       Development of a Zinc Finger Protein Therapeutic f for the Potential Treatment of Parkinson's Disease
(86) Sigma-Aldrich2033 Westport Center Drive
St Louis,MO63146 		84-1656258   49,353       Sigma breeding for rat characterization - Non-LRRK Non-LRRK2
(87) Sigma-Aldrich2033 Westport Center Drive
St Louis,MO63146 		84-1656258   46,850       Generation of KO Rat: LRRK1
(88) Sigma-Aldrich2033 Westport Center Drive
St Louis,MO63146 		84-1656258   24,676       Sigma breeding for rat characterization- LRRK2
(89) Signum Biosciences7 Deer Park Drive
Monmouth Junction,NJ08852 		01-0615746   164,625       Targeting alpha-Synuclein Dephosphorylation via PP PP2A Activation as a Novel PD Therapeutic
(90) Signum Biosciences7 Deer Park Drive
Monmouth Junction,NJ08852 		01-0615746   128,583       Characterization of PP2A as a Novel Therapeutic Ta Target and a Biomarker of PD
(91) SpringBox Ltd708 Congress Ave
Austin,TX78701 		  196,930       Fox Trial Finder Discovery and Build Out
(92) Stanford University318 Campus Drive West
Stanford,CA94305 		94-1156365 501(C)(3) 250,000       Developing optogenic technology for primates to un understand basal ganglia circuitry
(93) Stanford University269 Campus Drive
Stanford,CA94305 		94-1156365 501(C)(3) 103,913       Aldehyde Dehydrogenase Activators as Novel Treatme Treatment for Parkinson's disease
(94) Sun Health Research Institute10515 W Santa Fe Drive
Sun City,AZ85351 		86-0768795 501(C)(3) 257,031       PPMI Clinical Trial Site
(95) Sun Health Research Institute10515 W Santa Fe Drive
Sun City,AZ85351 		86-0768795 501(C)(3) 25,000       Compensation to Dr Beach re Novel Hypotheses in PD PD program
(96) SUNY Downstate Medical Center450 Clarkson Ave
Brooklyn,NY11203 		14-1368361 501(C)(3) 362,882       Optimization of optical coherence tomography as a biomarker for Parkinson's disease.
(97) Synthonics Inc1700 Kraft Drive
Blacksburg,VA24060 		20-3899302   270,850       Metal Complexation with Levodopa to Improve Contin Continuous Dopaminergic Stimulation
(98) Taconic5 Cedar Brook Drive
Cranbury,NJ08512 		33-0675808   178,520       Elan/MJFF Generation & Characterization (Phase 1) MJFF-6/7/8/9-P3520/P3521/P3522/P3523
(99) Taconic5 Cedar Brook Drive
Cranbury,NJ08512 		33-0675808   126,000       LRRK1 constitutive Gene KO mouse; Dual LRRK1/LRRK2 LRRK1/LRRK2 KO Mouse MJFF4/5-P3518/P3519
(100) Taconic5 Cedar Brook Drive
Cranbury,NJ08512 		33-0675808   97,150       LRRK2 dead kinase animal model MJFF-10/11/12-P352 MJFF-10/11/12-P3524/P3525/P3526"
(101) Taconic5 Cedar Brook Drive
Cranbury,NJ08512 		33-0675808   73,673       CJ Li Alpha-Synuclein Rat Housing
(102) Taconic5 Cedar Brook Drive
Cranbury,NJ08512 		33-0675808   49,115       CJ Li LRRK2 Rat Housing
(103) Texas A&M UniversityDepartment of Pathobiology
College Station,TX77843 		74-2245072 501(C)(3) 73,200       The role of alpha-synuclein in the pathogenesis of of Parkinson's disease in a rat animal model
(104) The Bachmann-Strauss Dystonia & Parkinson Foundati551 Fifth Avenue
New York,NY10176 		501(C)(3) 10,000       Support of Annual Think Tank
(105) The Buck Institute for Research on Aging8001 Redwood Blvd
Novato,CA94945 		94-3030609 501(C)(3) 125,000       Pharmacological PHD inhibition as a potential PD n neuroprotectant therapy
(106) The Burnham Institute for Medical Research10901 N Torrey Pines Rd
La Jolla,CA92017 		51-0197108 501(C)(3) 208,250       Quantitative Analysis of S-Nitrosylated Proteins i in Parkinson's Disease
(107) The Institute for Neurodegenerative Disorders60 Temple St Suite 8B
New Haven,CT06510 		06-1582206 501(C)(3) 675,434       PPMI 2010: Imaging Core
(108) The Institute for Neurodegenerative Disorders60 Temple St Suite 8B
New Haven,CT06510 		06-1582206 501(C)(3) 336,185       PPMI: Leadership Core 2010
(109) The Institute for Neurodegenerative Disorders60 Temple St Suite 8B
New Haven,CT06511 		06-1582206 501(C)(3) 257,031       PPMI Clinical Trial Site
(110) The Institute for Neurodegenerative Disorders60 Temple St Suite 8B
New Haven,CT06510 		06-1582206 501(C)(3) 15,492       PPMI Call Center
(111) The Jackson Laboratory610 Main Street
Bar Harbor,ME04609 		01-0211513 501(C)(3) 107,315       LRRK2 CJ Li Mouse Characterization Study 20010_BHC 20010_BHCB
(112) The Jackson Laboratory610 Main Street
Bar Harbor,ME04609 		01-0211513 501(C)(3) 21,000       JAX animal housing project - Cai
(113) The Jackson Laboratory610 Main Street
Bar Harbor,ME04609 		01-0211513 501(C)(3) 21,000       JAX animal housing project - Yue
(114) The Jackson Laboratory610 Main Street
Bar Harbor,ME04609 		01-0211513 501(C)(3) 14,000       JAX animal housing project- Cai
(115) The Jackson Laboratory610 Main Street
Bar Harbor,ME04609 		01-0211513 501(C)(3) 14,000       JAX animal housing project- Richfield
(116) The Parkinson's Institute675 Almanor Avenue
Sunnyvale,CA94085 		94-3061594 501(C)(3) 496,920       Establishing an LRRK2 Signaling Pathway and Assays for Patient Derived Samples
(117) The Parkinson's Institute675 Almanor Avenue
Sunnyvale,CA94085 		94-3061594 501(C)(3) 257,031       PPMI Clinical Trial Site
(118) The Scripps Research Institute5353 Parkside Drive
Jupiter,FL33458 		33-0435954 501(C)(3) 500,000       Probing the Function of SGK1 and its Relationship to LRRK2 and Parkinson?s Disease
(119) Thomas Jefferson University900 Walnut Street
Philadelphia,PA19107 		23-2829095 501(C)(3) 100,000       Gremlin-1 a putative VTA-derived Neuroprotective Factor in Parkinson's disease
(120) Translational Genomics Research Institute445 N 5th St
Phoenix,AZ85004 		75-3065445 501(C)(3) 75,000       MicroRNAs as biomarkers for Parkinson's disease; a comparison of CSF and blood
(121) Tufts-New England Medical Center800 Washington Street
Boston,MA02111 		501(C)(3) 75,000       Generation of a Novel Recombinant Protein Activator of GPR88
(122) University of Alabama at Birmingham1719 6th Ave South CIRC 516
Birmingham,AL35294 		60-0539600 501(C)(3) 257,031       PPMI Clinical Trial Site
(123) University of Alabama at Birmingham1719 6th Ave South CIRC 516
Birmingham,AL35294 		60-0539600 501(C)(3) 128,243       LRRK2 Dimerization as Pharmacodynamic Biomarkers of Activity
(124) University of Alabama at Birmingham1719 6th Ave South CIRC 516
Birmingham,AL35294 		60-0539600 501(C)(3) 39,836       Validation of VPS41 and TorsinA as Target for Parkinson Disease Therapy
(125) University of ArizonaCollege of Medicine
Tucson,AZ85724 		74-2652689 501(C)(3) 124,999       VEGF-B - a new neurotrophic factor for treatment for Parkinson's disease
(126) University of British Columbia3011-950 West 28th Avenue
Jacksonville,FL11111 		501(C)(3) 75,000       Characterization of PARK16
(127) University of California Irvine3238 McGaugh Hall
Irvine,CA92697 		95-2226406 501(C)(3) 101,250       Anti-amyloid oligomer monoclonal antibodies for treatment of Parkinson's Disease
(128) University of California Los Angeles635 Charles E Young Drive South
Los Angeles,CA90095 		95-6006143 501(C)(3) 297,793       PPMI 2010: Bioinformatics Core
(129) University of California Los Angeles710 Westwood Plaza
Los Angeles,CA90095 		95-6006143 501(C)(3) 250,000       Kynurenine 3-monooxygenase (KMO) as a target to develop drugs to block progression of PD.
(130) University of California Los Angeles635 Charles E Young Drive South
Los Angeles,CA90095 		95-6006143 501(C)(3) 156,306       Bioinformatics Core
(131) University of California San Diego9500 Gilman Drive
La Jolla,CA92093 		95-2544535 501(C)(3) 350,000       Preclinical study in a PD-like transgenic model of a novel isoindole compound that selectively blocks alpha-synuclein oligomerization
(132) University of California San Diego9500 Gilman Drive
San Diego,CA92093 		95-2544535 501(C)(3) 257,031       PPMI Clinical Trial Site
(133) University of Chicago5841 S Maryland Avenue MC 2030
Chicago,IL60637 		36-2177139 501(C)(3) 77,647       Oxidized DJ-1 as a biomarker for Parkinson's disease
(134) University of Colorado Denver12631 East 17th Avenue
Aurora,CO80045 		84-6000555 501(C)(3) 477,210       Acupuncture as a Symptomatic Treatment for Fatigue in Parkinson's Disease
(135) University of Colorado Denver12700 E 19th Ave
Aurora,CO80045 		84-6000555 501(C)(3) 125,000       Optimizing metalloporphryins for clinical development
(136) University of Florida100 S Newell Dr
Gainesville,FL32610 		59-6002052 501(C)(3) 132,777       Regulated rAAV-GDNF to treat Parkinson's disease: Translational research plan
(137) University of Iowa2450 University Capitol Center
Iowa City,IA52242 		42-6004813 501(C)(3) 202,208       PPMI 2010: Statistics Core
(138) University of Michigan530 Church Street
Ann Arbor,MI48109 		38-6006309 501(C)(3) 237,242       Treating early cognitive impairments and associated movement control deficits by stimulating alpha4beta2* nAChRs
(139) University of Mississippi2500 N State Street
Jackson,MS39216 		64-6008520 501(C)(3) 75,000       Increasing Endogenous Neurogenesis Using Neurosteroids: A Novel Therapeutic Strategy to Treat Parkinson's Disease
(140) University of Nebraska Medical CenterNebraska Medical Center
New Haven,CT68198 		47-0049123 501(C)(3) 75,000       Biomarkers and Immunotherapy for Parkinson's Disease
(141) University of Pennsylvania3400 Spruce Street
Philadelphia,PA19104 		23-1352685 501(C)(3) 375,506       PPMI 2010: Bioanalytics Core - Full Study
(142) University of Pennsylvania330 South 9th Street
Philadelphia,PA19104 		23-1352685 501(C)(3) 257,031       PPMI Clinical Trial Site
(143) University of Pennsylvania330 S 9th St
Philadelphia,PA19107 		23-1352685 501(C)(3) 8,000       PPMI Pre-Enrollment Consulting Fee
(144) University of Pittsburgh3501 Fifth Avenue
Pittsburgh,PA15260 		25-0965591 501(C)(3) 31,037       Male transgenic rat Parkinson's disease model characterization
(145) University of Rochester1351 Mt Hope Avenue Suite 216
Rochester,NY14620 		26-3800000   777,550       PPMI 2010: Clinical Core
(146) University of Rochester919 Westfall Road
Rochester,NY14618 		26-3800000 501(C)(3) 257,031       PPMI Clinical Trial Site
(147) University of South Florida4 Columbia Drive
Tampa,FL33606 		59-3102112 501(C)(3) 257,031       PPMI Clinical Trial Site
(148) University of Texas Health Science Center San Ant7703 Floyd Curl Drive
San Antonio,TX78229 		74-1586031 501(C)(3) 250,000       Peroxisome-Proliferator Activated Receptor gamma as a Target for Anti-Dyskinesia Pharmacotherapy
(149) University of Utah295 Chipeta Way
Salt Lake,UT84108 		87-6000525 501(C)(3) 47,463       Development of a novel zebrafish model to investigate the role of glucocerebrosidase in Parkinson's disease
(150) University of Washington1660 S Columbian Way
Seattle,WA98108 		91-6001537 501(C)(3) 257,031       PPMI Clinical Trial Site
(151) University of Washington1705 NE Pacific St
Seattle,WA98195 		91-6001537 501(C)(3) 15,251       Testing whether alpha-synuclein is modified by 4-hydroxy-2-nonenal in the human brain
(152) UT Southwestern Medical Center at Dallas (Universi5323 Harry Hines Blvd
Dallas,TX75390 		75-6002868 501(C)(3) 250,000       Post-translational modifications of LRRK2
(153) Van Andel Research Institute333 Bostwick Avenue NE
Grand Rapids,MI49503 		52-2000820 501(C)(3) 74,901       Circulating microRNAs as Biomarkers for Early Detection of Parkinson's Disease
(154) Virginia College of Osteopathic Medicine1861 Pratt Drive
Blacksburg,VA24060 		54-2052107 501(C)(3) 144,810       Cerium Oxide Nanoparticles in Treatment of Parkinson's Disease.
(155) Washington University in St Louis660 S Euclid
St Louis,MO63110 		43-0653611 501(C)(3) 184,045       Validation of Neuroimaging Biomarkers for Nigrostriatal Neurons
(156) WIL Research Laboratories1407 George Road
Ashland,OH44805 		26-0564612   319,000       Lrrk2 mouse characterization
(157) WIL Research Laboratories1407 George Road
Ashland,OH44805 		26-0564612   248,467       KO rat characterization
(158) WIL Research Laboratories1407 George Road
Ashland,OH44805 		26-0564612   124,233       KO rat characterization-LRRK2
(159) XenoPort3410 Central Expressway
Santa Clara,CA95051 		94-3330837   193,584       A Novel Prodrug of Acamprosate for Treatment of L-Dopa-Induced Dyskinesias
(160) Zaah Technologies6 Dubon Court
Jacksonville,FL11735 		68-0639784   62,000       Supplement for database development Clinicogenetic studies of Lrrk2 G2019S in Tunisia
(161) Zymes LLC777 Terrace Avenue
Hasbrouck Heights,NJ07604 		20-3153524   476,078       Evaluation of the neuroprotectivity ability of Zymes' water-soluble CoQ10 (WS-CoQ10) in animal models of PD; preclinical validation and dose optimization for clinical study
2
Enter total number of section 501(c)(3) and government organizations ......................... Bullet Image
100
3
Enter total number of other organizations ................................ . Bullet Image
58
For Privacy Act and Paperwork Reduction Act Notice, see the Instructions for Form 990.
Cat. No. 50055P
Schedule I (Form 990) 2010

Schedule I (Form 990) 2010
Page 2
Part III
Grants and Other Assistance to Individuals in the United States. Complete if the organization answered "Yes" to Form 990, Part IV, line 22.
Use Schedule I-1 (Form 990) if additional space is needed.
(a)Type of grant or assistance (b)Number of
recipients		 (c)Amount of
cash grant		 (d)Amount of
non-cash assistance		 (e)Method of valuation (book,
FMV, appraisal, other)		 (f)Description of non-cash assistance













Part IV
Supplemental Information. Complete this part to provide the information required in Part I, line 2, and any other additional information.
Identifier Return Reference Explanation
SCHEDULE I, PART I, LINE 2 PROCEDURES FOR MONITORING GRANT FUNDS IN THE UNITED STATES: THE FOUNDATION AWARDS RESEARCH GRANTS BASED UPON THE GUIDANCE AND INPUT OF THE SCIENTIFIC ADVISORY BOARD AND OTHER HIGHLY REGARDED SCIENTISTS WHO SERVE ON GRANT REVIEW COMMITTEES SPECIALIZING IN PARKINSON'S RESEARCH. Goals and milestones are described within each grant award. Most Grant awards are allocated in multiple payments with key benchmarks set at the time of the grant award. MJFF's Research team closely monitors the progress of each grant awarded. There is frequent communication between grantees and MJFF staff regarding the progress of each grant. Progress is verified before additional payments are made.
Schedule I (Form 990) 2010


Additional Data


Software ID:  
Software Version:  


Schedule J
(Form 990)
Department of the Treasury
Internal Revenue Service
Compensation Information
For certain Officers, Directors, Trustees, Key Employees, and Highest
Compensated Employees
SchJMediumBullet Complete if the organization answered "Yes" to Form 990,
Part IV, question 23.
SchJMediumBullet Attach to Form 990. SchJMediumBullet See separate instructions.
OMB No. 1545-0047
2010
Open to Public Inspection
Name of the organization
The Michael J Fox Foundation
FOR PARKINSON'S RESEARCH
Employer identification number

13-4141945
Part I
Questions Regarding Compensation
Yes
No
1a
Check the appropiate box(es) if the organization provided any of the following to or for a person listed in Form
990, Part VII, Section A, line 1a. Complete Part III to provide any relevant information regarding these items.
b
If any of the boxes in line 1a are checked, did the organization follow a written policy regarding payment or reimbursement orprovision of all the expenses described above? If "No," complete Part III to explain....
1b
 
 
2
Did the organization require substantiation prior to reimbursing or allowing expenses incurred by all
officers, directors, trustees, and the CEO/Executive Director, regarding the items checked in line 1a? ....
2
 
 
3
Indicate which, if any, of the following the organization uses to establish the compensation of the
organization's CEO/Executive Director. Check all that apply.
4
During the year, did any person listed in Form 990, Part VII, Section A, line 1a with respect to the filing organization or a related organization:
a
Receive a severance payment or change-of-control payment? ...............
4a
 
No
b
Participate in, or receive payment from, a supplemental nonqualified retirement plan? ........
4b
 
No
c
Participate in, or receive payment from, an equity-based compensation arrangement? ........
4c
 
No
If "Yes" to any of lines 4a-c, list the persons and provide the applicable amounts for each item in Part III.
Only 501(c)(3) and 501(c)(4) organizations only must complete lines 5-9.
5
For persons listed in form 990, Part VII, Section A, line 1a, did the organization pay or accrue any
compensation contingent on the revenues of:
a
The organization? ...........................
5a
 
No
b
Any related organization? .........................
5b
 
No
If "Yes," to line 5a or 5b, describe in Part III.
6
For persons listed in form 990, Part VII, Section A, line 1a, did the organization pay or accrue any
compensation contingent on the net earnings of:
a
The organization? ...........................
6a
 
No
b
Any related organization? .........................
6b
 
No
If "Yes," to line 6a or 6b, describe in Part III.
7
For persons listed in Form 990, Part VII, Section A, line 1a, did the organization provide any non-fixed
payments not described in lines 5 and 6? If "Yes," describe in Part III ............
7
 
No
8
Were any amounts reported in Form 990, Part VII, paid or accured pursuant to a contract that was
subject to the initial contract exception described in Regs. section 53.4958-4(a)(3)? If "Yes," describe
in Part III .............................
8
 
No
9
If "Yes" to line 8, did the organization also follow the rebuttable presumption procedure described in Regulations section 53.4958-6(c)? .........................
9
 
 
For Privacy Act and Paperwork Reduction Act Notice, see the Intructions for Form 990
Cat. No. 50053T
Schedule J (Form 990) 2010

Schedule J (Form 990) 2010
Page 2
Part II
Officers, Directors, Trustees, Key Employees, and Highest Compensated Employees. Use Schedule J-1 if additional space needed.
For each individual whose compensation must be reported in Schedule J, report compensation from the organization on row (i) and from related organizations, described in the
instructions on row (ii). Do not list any individuals that are not listed on Form 990, Part VII.

Note. The sum of columns (B)(i)-(iii) must equal the applicable column (D) or column (E) amounts on Form 990, Part VII, line 1a.
(A) Name (B) Breakdown of W-2 and/or 1099-MISC compensation (C) Retirement and other deferred compensation (D) Nontaxable
benefits		 (E) Total of columns
(B)(i)-(D) 		(F) Compensation
reported in prior
Form 990 or
Form 990-EZ
(i) Base compensation (ii) Bonus & incentive compensation (iii) Other reportable compensation
(1) KATHERINE H HOOD (i)
(ii)		 283,344
0 		180,000
0 		7,279
0 		7,350
0 		403
0 		478,376
0 		0
0
(2) JOANNE MARTZ (i)
(ii)		 180,396
0 		45,000
0 		0
0 		6,762
0 		12,573
0 		244,731
0 		0
0
(3) Todd Sherer (i)
(ii)		 225,496
0 		100,000
0 		0
0 		7,350
0 		12,573
0 		345,419
0 		0
0
(4) KAREN LEIES (i)
(ii)		 179,125
0 		43,000
0 		0
0 		6,664
0 		17,827
0 		246,616
0 		0
0
(5) DEBORAH W BROOKS (i)
(ii)		 275,606
0 		165,000
0 		0
0 		7,350
0 		17,827
0 		465,783
0 		0
0
(6) John T Grant (i)
(ii)		 120,796
0 		15,000
0 		10,000
0 		4,062
0 		6,127
0 		155,985
0 		0
0
(7) SHEILA KELLY (i)
(ii)		 130,287
0 		16,000
0 		0
0 		4,389
0 		5,775
0 		156,451
0 		0
0
(8) Brian K Fiske (i)
(ii)		 129,653
0 		13,000
0 		0
0 		4,053
0 		12,573
0 		159,279
0 		0
0








Schedule J (Form 990) 2010

Schedule J (Form 990) 2010
Page 3
Part III
Supplemental Information
Complete this part to provide the information, explanation, or descriptions required for Part I, lines 1a, 1b, 4c, 5a, 5b, 6a, 6b, 7, and 8. Also complete this part for any additional information.
Identifier Return Reference Explanation
Schedule J (Form 990) 2010

Additional Data


Software ID:  
Software Version:  
Schedule L
(Form 990 or 990-EZ)
Department of the Treasury
Internal Revenue Service
Transactions with Interested Persons
MediumBullet Complete if the organization answered
"Yes" on Form 990, Part IV, lines 25a, 25b, 26, 27, 28a, 28b, or 28c,
or Form 990-EZ, Part V lines 38a or 40b.
MediumBullet Attach to Form 990 or Form 990-EZ. MediumBulletSee separate instructions.
OMB No. 1545-0047
2010
Open to Public Inspection
Name of the organization
The Michael J Fox Foundation
FOR PARKINSON'S RESEARCH
Employer identification number

13-4141945
Part I
Excess Benefit Transactions (section 501(c)(3) and section 501 (c)(4) organizations only).
Complete if the organization answered "Yes" on Form 990, Part IV, line 25a or 25b, or Form 990-EZ, Part V, line 40b.
1(a) Name of disqualified person (b) Description of transaction (c) Corrected?
Yes No





2
Enter the amount of tax imposed on the organization managers or disqualified persons during the year under section 4958. ......................... Bullet Image$
 
3
Enter the amount of tax, if any, on line 2, above, reimbursed by the organization ....... Bullet Image$
 

Part II
Loans to and/or From Interested Persons.
Complete if the organization answered "Yes" on Form 990, Part IV, line 26, or Form 990-EZ, Part V, line 38a.
(a) Name of interested person and purpose (b) Loan to or from the organization? (c)Original principal amount (d)Balance due (e) In default? (f) Approved by board or committee? (g)Written agreement?
To From Yes No Yes No Yes No
Total ...............Small Bullet $  
Part III
Grants or Assistance Benefitting Interested Persons.
Complete if the organization answered "Yes" on Form 990, Part IV, line 27.
(a) Name of interested person (b)Relationship between interested person and the organization (c)Amount of grant or type of assistance
For Privacy Act and Paperwork Reduction Act Notice, see the
Instructions for Form 990 or 990-EZ.
Cat. No. 50056A
Schedule L (Form 990 or 990-EZ) 2010
Schedule L (Form 990 or 990-EZ) 2010
Page 2
Part IV
Business Transactions Involving Interested Persons.
Complete if the organization answered "Yes" on Form 990, Part IV, line 28a, 28b, or 28c.
(a) Name of interested person (b) Relationship between interested person and the organization (c) Amount of transaction (d) Description of transaction (e) Sharing of organization's revenues?
Yes No
(1) Donny Deutsch Board of Directors 60,865 Design and Creative Services   No
Part V
Supplemental Information
Complete this part to provide additional information for responses to questions on Schedule L (see instructions).
Identifier Return Reference Explanation
SCHEDULE L, PART IV BUSINESS TRANSACTIONS INVOLVING INTERESTED PERSONS THE FOUNDATION INCURRED DESIGN AND CREATIVE ADVICE EXPENSES OF $60,865 FOR SERVICES RENDERED BY A COMMUNICATIONS, BRAND DEVELOPMENT AND DESIGN AGENCY, THE CHAIRMAN OF WHICH IS A FOUNDATION BOARD MEMBER. THE FOUNDATION ALSO PROVIDED A $15,000 GRANT TO A RESEARCH FIRM FOR THE PURPOSES OF PERFORMING A STUDY OF PARKINSON'S DISEASE, THE PARTNER AND MANAGING DIRECTOR OF WHICH IS A MEMBER OF THE FOUNDATION'S BOARD.
Schedule L (Form 990 or 990-EZ) 2010

Additional Data


Software ID:  
Software Version:  




SCHEDULE M
(Form 990)

Department of the Treasury
Internal Revenue Service
NonCash Contributions
Right pointing arrow large imageComplete if the organization answered "Yes" on Form 990, Part IV, lines 29 or 30.
Right pointing arrow large image Attach to Form 990.
OMB No. 1545-0047
2010
Open to Public Inspection
Name of the organization
The Michael J Fox Foundation
FOR PARKINSON'S RESEARCH
Employer identification number

13-4141945
Part I
Types of Property
(a)
Check if applicable 		(b)
Number of Contributions or items contributed 		(c)
Contribution amounts reported on
Form 990, Part VIII, line 1g 		(d)
Method of determining
contribution amounts
1 Art—Works of art ....        
2 Art—Historical treasures .        
3 Art—Fractional interests ..        
4 Books and publications ..      
5 Clothing and household
goods ....... 		     
6 Cars and other vehicles ..        
7 Boats and planes ....        
8 Intellectual property ...        
9 Securities—Publicly traded . X 36 5,398,435 FAIR VALUE
10 Securities—Closely held stock .        
11 Securities—Partnership, LLC,
or trust interests .... 		       
12 Securities—Miscellaneous ..        
13 Qualified conservation
contribution—Historic
structures ..... 		       
14 Qualified conservation
contribution—Other ... 		       
15 Real estate—Residential .        
16 Real estate—Commercial ..        
17 Real estate—Other ...        
18 Collectibles .....        
19 Food inventory ...        
20 Drugs and medical supplies .        
21 Taxidermy ......        
22 Historical artifacts ....        
23 Scientific specimens ..        
24 Archeological artifacts ...        
25 Other Right pointing arrow large image ( )
26 Other Right pointing arrow large image( )
27 Other Right pointing arrow large image( )
28 Other Right pointing arrow large image ( )
29
Number of Forms 8283 received by the organization during the tax year for contributions
for which the organization completed Form 8283, Part IV, Donee Acknowledgement ...
29
 
Yes
No
30a
During the year, did the organization receive by contribution any property reported in Part I, lines 1-28 that it
must hold for at least three years from the date of the initial contribution, and which is not required to be used
for exempt purposes for the entire holding period? ..................
30a
 
No
b
If "Yes," describe the arrangement in Part II.
31
Does the organization have a gift acceptance policy that requires the review of any non-standard contributions?
31
Yes
 
32a
Does the organization hire or use third parties or related organizations to solicit, process, or sell non-cash
contributions? ............................
32a
 
No
b
If "Yes," describe in Part II.
33
If the organization did not report revenues in column (c) for a type of property for which column (a) is checked,
describe in Part II.
For Privacy Act and Paperwork Reduction Act Notice, see the Instructions for Form 990.
Cat. No. 51227J
Schedule M (Form 990) 2010
Schedule M (Form 990) 2010
Page 2
Part II
Supplemental Information. Complete this part to provide the information required by Part I, lines 30b,
32b, and 33. Also complete this part for any additional information.
Identifier Return Reference Explanation
Schedule M (Form 990) 2010
Additional Data


Software ID:  
Software Version:  
SCHEDULE O
(Form 990 or 990-EZ)

Department of the Treasury
Internal Revenue Service
Supplemental Information to Form 990 or 990-EZ

Complete to provide information for responses to specific questions on
Form 990 or to provide any additional information.
MediumBullet Attach to Form 990 or 990-EZ.
OMB No. 1545-0047
2010
Open to Public
Inspection
Name of the organization
The Michael J Fox Foundation
FOR PARKINSON'S RESEARCH
Employer identification number

13-4141945
Identifier Return Reference Explanation
FORM 990, PAGE 1, LINE 1 AND PAGE 2, LINE 1   FINDING THE CURE FOR PARKINSON'S TAKES AN ORGANIZATION WITH EXTRAORDINARY VISION. The Michael J. Fox Foundation for Parkinson's Research is committed to a focused, proactive strategy to do whatever it takes to speed transformative treatments to the nearly five million people living with Parkinson's disease worldwide. We are working to maximize impact by pushing basic discoveries toward clinical trials and strategically targeting resources toward critical research hurdles that other funders cannot or will not prioritize. As the largest non-government funder of Parkinson's research, we stand ready to forge a new model of what a research funding organization can be - stepping up to deliver Parkinson's solutions and, in the process, transforming a flawed biomedical research system in ways that ultimately could impact every life touched by illness or injury.
Form 990, Page 6 Governance, Management and Disclosure Line 2: TWO BOARD MEMBERS ARE MARRIED TO ONE ANOTHER. TWO BOARD MEMBERS ARE IN-LAWS. Line 11A: Process for Review of Form 990: The Finance Committee of the Board of Directors, in association with external auditors, approves the annual IRS Form 990 which is then made available to the entire Board before it is filed. Line 12A: Conflict of Interest Policy monitoring: Officers, directors and key employees complete a conflict of interest questionnaire annually. The information is reviewed by the VP, Administration, and conflicts are reviewed with the Board of Directors. Line 15: Compensation Determination: The Compensation Committee of the Board of Directors reviews and approves compensation of key employees annually. Line 19: Governing documents are available upon request. - Conflict of interest policy is available upon request. - Financial statements are available at www.michaeljfox.org.
For Paperwork Reduction Act Notice, see the Instructions for Form 990 or 990-EZ.
Cat. No. 51056K
Schedule O (Form 990 or 990-EZ) 2010

Additional Data


Software ID:  
Software Version:  
SCHEDULE R
(Form 990)
Department of the Treasury
Internal Revenue Service
Related Organizations and Unrelated Partnerships
MediumBulletComplete if the organization answered "Yes" to Form 990, Part IV, line 33, 34, 35, 36, or 37.
MediumBulletAttach to Form 990. MediumBullet See separate instructions.

OMB No. 1545-0047
2010
Open to Public Inspection
Name of the organization
The Michael J Fox Foundation
FOR PARKINSON'S RESEARCH
Employer identification number

13-4141945
Part I
Identification of Disregarded Entities (Complete if the organization answered "Yes" on Form 990, Part IV, line 33.)
(a)
Name, address, and EIN of disregarded entity


(b)
Primary activity


 		(c)
Legal domicile (state
or foreign country)

 		(d)
Total income
(e)
End-of-year assets


 		(f)
Direct controlling
entity

















Part II
Identification of Related Tax-Exempt Organizations (Complete if the organization answered "Yes" on Form 990, Part IV, line 34 because it had one or more related tax-exempt organizations during the tax year.)
(a)
Name, address, and EIN of related organization


(b)
Primary activity


 		(c)
Legal domicile (state
or foreign country)

 		(d)
Exempt Code section
(e)
Public charity status
(if section 501(c)(3))

 		(f)
Direct controlling
entity

 		(g)
Section 512(b)(13) controlled organization
Yes No
(1) MJFF CANADA

365 Bay Street Suite 899
Toronto,Ontario  
CA
RESEARCH CA     MJFF (US)
 
 
 












For Privacy Act and Paperwork Reduction Act Notice, see the Instructions for Form 990.
Cat. No. 50135Y
Schedule R (Form 990) 2010
Schedule R (Form 990) 2010
Page 2
Part III
Identification of Related Organizations Taxable as a Partnership (Complete if the organization answered "Yes" on Form 990, Part IV, line 34 because it had one or more related organizations treated as a partnership during the tax year.)
(a)
Name, address, and EIN of
related organization



 		(b)
Primary activity




 		(c)
Legal
domicile
(state or foreign
country)


 		(d)
Direct controlling
entity



 		(e)
Predominant income(related, unrelated, excluded from tax under sections 512-514)

(f)
Share of total income




 		(g)
Share of end-of-year
assets



 		(h)
Disproprtionate allocations?




 		(i)
Code V—UBI
amount in box 20 of
Schedule K-1
(Form 1065)
 		(j)
General or
managing
partner?



 		(k)
Percentage
ownership
Yes No Yes No












Part IV
Identification of Related Organizations Taxable as a Corporation or Trust (Complete if the organization answered "Yes" on Form 990, Part IV, line 34 because it had one or more related organizations treated as a corporation or trust during the tax year.)
(a)
Name, address, and EIN of related organization



 		(b)
Primary activity



 		(c)
Legal domicile
(state or
foreign
country)
 		(d)
Direct controlling
entity


 		(e)
Type of entity
(C corp, S corp,
or trust)

 		(f)
Share of total income



 		(g)
Share of
end-of-year
assets

 		(h)
Percentage
ownership












Schedule R (Form 990) 2010
Schedule R (Form 990) 2010
Page 3
Part V
Transactions With Related Organizations (Complete if the organization answered "Yes" on Form 990, Part IV, line 34, 35, 35A, or 36.)
Note. Complete line 1 if any entity is listed in Parts II, III or IV.
Yes
No
1 During the tax year, did the orgranization engage in any of the following transactions with one or more related organizations listed in Parts II-IV?
a Receipt of (i) interest (ii) annuities (iii) royalties (iv) rent from a controlled entity . . . . . . . . . . . . . . . . . . . . . . .
1a
 
No
b Gift, grant, or capital contribution to other organization(s) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
1b
 
No
c Gift, grant, or capital contribution from other organization(s) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
1c
Yes
 
d Loans or loan guarantees to or for other organization(s) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
1d
 
No
e Loans or loan guarantees by other organization(s) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
1e
 
No
f Sale of assets to other organization(s) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
1f
 
No
g Purchase of assets from other organization(s) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
1g
 
No
h Exchange of assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
1h
 
No
i Lease of facilities, equipment, or other assets to other organization(s) . . . . . . . . . . . . . . . . . . . . . . . . . . . .
1i
 
No
j Lease of facilities, equipment, or other assets from other organization(s) . . . . . . . . . . . . . . . . . . . . . . . . . . .
1j
 
No
k Performance of services or membership or fundraising solicitations for other organization(s) . . . . . . . . . . . . . . . . . . . . . .
1k
 
No
l Performance of services or membership or fundraising solicitations by other organization(s) . . . . . . . . . . . . . . . . . . . . . .
1l
 
No
m Sharing of facilities, equipment, mailing lists, or other assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
1m
 
No
n Sharing of paid employees . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
1n
 
No
o Reimbursement paid to other organization for expenses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
1o
 
No
p Reimbursement paid by other organization for expenses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
1p
 
No
q Other transfer of cash or property to other organization(s) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
1q
 
No
r Other transfer of cash or property from other organization(s) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
1r
 
No
2
If the answer to any of the above is "Yes," see the instructions for information on who must complete this line, including covered relationships and transaction thresholds.
(a)
Name of other organization 		(b)
Transaction
type(a-r) 		(c)
Amount involved 		(d)
Method of determining amount involved
(1) THE MICHAEL J FOX FOUNDATION (CANADA)

 C 194,518  
(1)
(2)
(3)
(4)
(5)
(6)
Schedule R (Form 990) 2010
Schedule R (Form 990) 2010
Page 4
Part VI
Unrelated Organizations Taxable as a Partnership (Complete if the organization answered "Yes" on Form 990, Part IV, line 37.)
Provide the following information for each entity taxed as a partnership through which the organization conducted more than five percent of its activities (measured by total assets or gross revenue) that was not a related organization. See instructions regarding exclusion for certain investment partnerships.
(a)
Name, address, and EIN of entity 		(b)
Primary activity 		(c)
Legal domicile
(state or foreign
country) 		(d)
Are all
partners
section
501(c)(3)
organizations? 		(e)
Share of
end-of-year
assets 		(f)
Disproprtionate allocations? 		(g)
Code V—UBI
amount in box
20 of Schedule K-1
(Form 1065) 		(h)
General or
managing
partner?
Yes No Yes No Yes No






























Schedule R (Form 990) 2010
Schedule R (Form 990) 2010
Page 5
Part VII
Supplemental Information
Complete this part to provide additional information for responses to questions on Schedule R (see instructions).
Identifier Return Reference Explanation
Additional Data


Software ID:  
Software Version: